SlideShare une entreprise Scribd logo
1  sur  11
Télécharger pour lire hors ligne
The new engl and jour nal of medicine
n engl j med 376;7 nejm.org  February 16, 2017 663
From the Department of Health Policy
and Management, Harvard T.H. Chan
School of Public Health (M.L.B.), the De-
partment of Health Care Policy, Harvard
Medical School (A.R.O., A.B.J.), the Divi-
sion of General Internal Medicine and
Primary Care, Department of Medicine,
Brigham and Women’s Hospital (M.L.B.),
and the Department of Medicine, Massa-
chusetts General Hospital (A.B.J.), Boston,
and the National Bureau of Economic Re-
search, Cambridge (A.B.J.) — all in Massa-
chusetts. Address reprint requests to Dr.
Barnett at the Department of Health Pol-
icy and Management, Harvard T.H. Chan
School of Public Health, Kresge Bldg.,
4th Fl., 677 Huntington Ave., Boston, MA
02115, or at ­mbarnett@​­hsph​.­harvard​.­edu.
This article was updated on February 16,
2017, at NEJM.org.
N Engl J Med 2017;376:663-73.
DOI: 10.1056/NEJMsa1610524
Copyright © 2017 Massachusetts Medical Society.
BACKGROUND
Increasing overuse of opioids in the United States may be driven in part by physician
prescribing. However, the extent to which individual physicians vary in opioid pre-
scribing and the implications of that variation for long-term opioid use and adverse
outcomes in patients are unknown.
METHODS
We performed a retrospective analysis involving Medicare beneficiaries who had
an index emergency department visit in the period from 2008 through 2011 and
had not received prescriptions for opioids within 6 months before that visit. After
identifying the emergency physicians within a hospital who cared for the patients,
we categorized the physicians as being high-intensity or low-intensity opioid prescrib-
ers according to relative quartiles of prescribing rates within the same hospital. We
compared rates of long-term opioid use, defined as 6 months of days supplied, in
the 12 months after a visit to the emergency department among patients treated
by high-intensity or low-intensity prescribers, with adjustment for patient charac-
teristics.
RESULTS
Our sample consisted of 215,678 patients who received treatment from low-inten-
sity prescribers and 161,951 patients who received treatment from high-intensity
prescribers. Patient characteristics, including diagnoses in the emergency depart-
ment, were similar in the two treatment groups. Within individual hospitals, rates
of opioid prescribing varied widely between low-intensity and high-intensity pre-
scribers (7.3% vs. 24.1%). Long-term opioid use was significantly higher among
patients treated by high-intensity prescribers than among patients treated by low-
intensity prescribers (adjusted odds ratio, 1.30; 95% confidence interval, 1.23 to 1.37;
P<0.001); these findings were consistent across multiple sensitivity analyses.
CONCLUSIONS
Wide variation in rates of opioid prescribing existed among physicians practicing
within the same emergency department, and rates of long-term opioid use were in-
creased among patients who had not previously received opioids and received
treatment from high-intensity opioid prescribers. (Funded by the National Insti-
tutes of Health.)
ABSTR ACT
Opioid-Prescribing Patterns of Emergency
Physicians and Risk of Long-Term Use
Michael L. Barnett, M.D., Andrew R. Olenski, B.S.,
and Anupam B. Jena, M.D., Ph.D.​​
Special Article
The New England Journal of Medicine
Downloaded from nejm.org on February 15, 2017. For personal use only. No other uses without permission.
Copyright © 2017 Massachusetts Medical Society. All rights reserved.
n engl j med 376;7 nejm.org  February 16, 2017664
The new engl and jour nal of medicine
R 
ates of opioid prescribing and
opioid-related overdose deaths have qua-
drupled in the United States over the past
three decades.1-3
This epidemic has increasingly
affected the elderly Medicare population, among
whom rates of hospitalization for opioid overdoses
quintupled from 1993 through 2012.4-6
The risks
of opioid use are particularly pronounced among
the elderly, who are vulnerable to their sedating
side effects, even at therapeutic doses.7
Multiple
studies have shown increased rates of falls, frac-
tures, and death from any cause associated with
opioid use in this population.8-11
Even short-term
opioid use may confer a predisposition to these
side effects and to opioid dependence.12
It is frequently argued that the prescribing be-
havior of physicians has been a driver of the opioid
epidemic.13,14
Prescribing has increased to the point
that in 2010, enough opioids were prescribed in
the United States to provide every American adult
with 5 mg of hydrocodone every 4 hours for a
month.1,14
This growth may be driven in part by
high variability in physician prescribing of opi-
oids; this variability may reflect overprescribing
beyond what is required for appropriate pain
management.1,15,16
This inconsistency is not sur-
prising, because few clinical guidelines exist, and
there is limited evidence to direct the appropri-
ate use of opioids.17,18
However, few studies have
investigated the extent to which individual phy-
sicians vary in opioid prescribing and the impli-
cations of that variation for long-term opioid use
and related adverse outcomes in patients.
To examine the extent to which emergency phy-
sicians within the same hospital varied in rates of
opioid prescribing, we studied a national sample of
Medicare beneficiaries who received treatment in
an emergency department and who had not used
prescription opioids within 6 months before the
index visit to the emergency department. In order
to understand how initial exposure to an opioid
relates to subsequent outcomes, we identified high-
intensity and low-intensity opioid prescribers with-
in each hospital and examined rates of long-term
opioid use and future hospitalizations among pa-
tients treated by these two groups of prescrib-
ers.19,20
To address the challenge of selection bias,
we relied on the fact that patients are unlikely to
choose an emergency department physician once
they have chosen a facility.
Methods
Study Population
Using the Centers for Medicare and Medicaid Ser-
vices carrier files for a 20% random sample of
beneficiaries from January 1, 2008, through De-
cember 31, 2011, we identified index emergency
department visits at acute care hospitals by Medi-
care beneficiaries. We defined an index visit as the
earliest visit at which a beneficiary had an evalu-
ation and a management claim by an emergency
medicine physician with a place-of-service desig-
nation in the emergency department. Emergency
medicine physicians were defined as physicians
with an emergency medicine specialty who
billed 90% or more of claims with an emergency
department place of service. We included only
one index visit to the emergency department per
beneficiary and excluded all visits to the emer-
gency department that resulted in a hospital ad-
mission.
We limited our analyses to beneficiaries who
had been continuously enrolled in Medicare Part D
for 18 months or more, including at least the
period from 6 months before the index visit to
12 months afterward. We included only beneficia-
ries who had not had an opioid prescription filled
in the 6 months before the index visit. In addition,
we excluded beneficiaries with hospice claims or a
cancer diagnosis between 2008 and 2012.
We assigned each index emergency department
visit to a physician according to the billing Na-
tional Provider Identifier (NPI) and then linked
each visit to a hospital by matching to facility
claims in the outpatient department file according
to the date and beneficiary. To ensure that we had
an adequate sample size at the physician and hos-
pital level, we excluded physicians with fewer than
five emergency department visits and hospitals
with fewer than five physicians billing for emer-
gency department visits in our sample. If physi-
cians practiced in more than one hospital, they
were assigned to the hospital at which they had the
most visits, and any visits at other facilities were
excluded.
This study was approved by the institutional
review board at Harvard Medical School, which
waived the requirement for informed consent
since the data were deidentified and only aggre-
gate results would be reported.
The New England Journal of Medicine
Downloaded from nejm.org on February 15, 2017. For personal use only. No other uses without permission.
Copyright © 2017 Massachusetts Medical Society. All rights reserved.
n engl j med 376;7 nejm.org  February 16, 2017 665
Opioid Prescribing and Risk of Long-Term Use
Definitions of Opioid Prescriptions
and Intensity of Physicians’ Prescribing
We identified prescription claims corresponding
to an opioid (excluding methadone) according to
the National Drug Code in the Medicare Part D
database.16
We attributed an opioid prescription to
an index emergency department visit and the as-
sociated physician if it was filled by the patient
within 7 days after the date of the emergency de-
partment visit; in a sensitivity analysis, we restrict-
ed this duration to 3 days. This attribution method
was necessary because prescriber NPI informa-
tion is not available in the Part D database (see
the Methods and Results section in the Supple-
mentary Appendix, available with the full text of
this article at NEJM.org). For this and subsequent
opioid prescriptions, we extracted the number of
days for which opiates were supplied and calcu-
lated the morphine equivalents dispensed, using
standard conversion tables.21
We defined the main exposure as treatment
by a “high-intensity” or “low-intensity” opioid pre-
scribing physician within the same hospital. For
each physician, we first calculated the proportion
of all emergency department visits after which an
opioid prescription was filled. We then grouped
physicians into quartiles of rates of opioid pre-
scribing within each hospital and classified physi-
cians as being in the top (high-intensity) or bot-
tom (low-intensity) quartile of prescribing rates. In
93 hospitals, because of a high number of pre-
scribers who did not prescribe opioids, there were
fewer than four separate groups of prescribers to
assign to quartiles; therefore, the highest and low-
est prescribers in a hospital were assigned to the
high-intensity and low-intensity groups. We also
defined an alternative exposure, classifying phy-
sicians according to the median dose (in morphine
equivalents) of prescriptions filled after an emer-
gency department visit (“high-dose intensity” and
“low-dose intensity”).
Outcomes
Our primary outcome was long-term opioid use,
which we defined as 180 days or more of opioids
supplied in the 12 months after an index emer-
gency department visit, excluding prescriptions
within 30 days after the index visit. We applied this
exclusion because otherwise this outcome, by de-
sign, would be correlated with our definition of
the main exposure. We chose 180 days as a spe-
cific marker for clinically significant long-term
opioid use beyond the common duration of 90 days
described in previous literature.16,22,23
Therefore,
this outcome captures the extent to which other
physicians prescribe opioids for the subsequent
12 months after a patient’s index emergency de-
partment visit.
Secondary outcomes were rates of hospital
encounters (emergency department visits, hospi-
talizations, or both), including those potentially
related to adverse effects of opioids and those
associated with a selection of medical conditions
that were unlikely to be influenced by opioid use,
in the 12 months after an index emergency depart-
ment visit (definitions are provided in the Methods
and Results section in the Supplementary Appen-
dix).8-10,24
To assess for possible undertreatment of
pain by low-intensity prescribers that could have
led to repeat emergency care, we also measured
rates of repeat emergency department visits at 14
and 30 days that resulted in the same primary di-
agnosis as the initial emergency department visit,
classified according to Clinical Classifications Soft-
ware (CCS) groups (categorizations of codes in the
International Classification of Diseases, 9th Revision).25
Patient Covariates
We collected information on the patients’ age, sex,
race or ethnic group, dual eligibility for Medicaid
and Medicare coverage, and disability status.26
Us-
ing the Chronic Conditions Warehouse database,
we also captured the presence of any of 11 chronic
conditions (Table 1) as well as the number of coex-
isting chronic conditions that a patient had at the
time of an index emergency department visit.
Statistical Analysis
Our strategy to reduce selection bias relied on the
assumption that within the same hospital, patients
do not choose specific emergency physicians, and
therefore patients treated by physicians of varying
opioid prescribing intensity may be similar with
respect to both observable and unobservable char-
acteristics. To assess this approach, we compared
the characteristics of patients who saw high-inten-
sity prescribers with those who saw low-intensity
prescribers. We assessed balance in the case mix
by comparing rates of visits classified according to
the top 25 CCS groups, as well as by plotting the
The New England Journal of Medicine
Downloaded from nejm.org on February 15, 2017. For personal use only. No other uses without permission.
Copyright © 2017 Massachusetts Medical Society. All rights reserved.
n engl j med 376;7 nejm.org  February 16, 2017666
The new engl and jour nal of medicine
cumulative distribution of the primary-diagnosis
CCS group between high-intensity and low-inten-
sity prescribers. Differences in distributions be-
tween groups were assessed with the use of the
Kolmogorov–Smirnov test.27
We then computed unadjusted rates and odds
ratios for each outcome, stratified according to
treatment by a high-intensity or low-intensity
opioid prescriber. To account for residual differ-
ences between patient populations, we estimated
adjusted odds ratios with patient-level multivari-
able logistic regression. Dependent variables were
the occurrence of primary or secondary outcomes.
The key explanatory variable was a binary indica-
tor for whether a patient was treated by a high-
intensity or low-intensity prescriber (the middle
two quartiles of prescribers were not included in
these models). Other covariates included the
patients’ age, sex, race or ethnic group, Medicaid
eligibility, and disability status, as well as the
presence of 11 different chronic conditions. We
prespecified several subgroup analyses to assess
for heterogeneity (Table 2). All models account-
ed for grouping of patients within hospitals with
Characteristic
Patients Treated by
Low-Intensity Prescriber
(N = 215,678)†
Patients Treated by
High-Intensity Prescriber
(N = 161,951)† P Value‡
Age (yr) 68.8±16.3 68.2±16.4 <0.001
Female sex (%) 64.5 64.5 0.75
White race (%)§ 76.6 75.9 0.03
Medicare–Medicaid dual eligibility (%) 49.3 49.6 0.19
Disabled (%) 36.4 37.6 <0.001
Chronic conditions (no.) 3.6±2.3 3.5±2.3 <0.001
Presence of chronic illness (%)
Acute myocardial infarction 49.8 48.5 <0.001
Alzheimer’s dementia 17.5 16.0 <0.001
Atrial fibrillation 13.6 12.7 <0.001
Cerebrovascular disease 17.3 16.3 <0.001
Chronic kidney disease 20.6 20.1 <0.001
Chronic obstructive pulmonary disease 28.1 27.2 <0.001
Congestive heart failure 30.5 29.0 <0.001
Depression 39.5 39.5 0.94
Diabetes 37.8 37.7 0.69
Hyperlipidemia 69.5 69.1 0.09
Hypertension 78.1 77.4 <0.001
Census region (%)
Northeast 19.8 20.9 0.03
Midwest 24.4 23.2 0.01
South 38.4 38.6 0.82
West 17.3 17.3 0.97
*	Plus–minus values are means ±SD.
†	Within each hospital, high-intensity and low-intensity prescribers were defined as the top (high) or bottom (low) quar-
tile of emergency physician prescribers in terms of opioid prescribing. Since many physicians did not prescribe opioids,
some hospitals had many physicians with prescribing rates equal to zero in the low-intensity prescriber group, making
it larger overall than the high-intensity group. Low-intensity prescribers included 8297 physicians; the total number (±SD)
of patients per physician was 26.0±18.6. High-intensity prescribers included 6133 physicians; the total number of pa-
tients per physician was 26.4±18.5.
‡	Unadjusted P values were estimated with the use of Student’s t-test for means or the z-test for comparison of proportions.
§	Race or ethnic group was self-reported.
Table 1. Characteristics of the Patients, According to Opioid Prescribing Intensity of Physician Seen.*
The New England Journal of Medicine
Downloaded from nejm.org on February 15, 2017. For personal use only. No other uses without permission.
Copyright © 2017 Massachusetts Medical Society. All rights reserved.
n engl j med 376;7 nejm.org  February 16, 2017 667
Opioid Prescribing and Risk of Long-Term Use
the use of robust standard errors clustered at the
hospital level.28
The hypothetical long-term effect of filling
an initial opioid prescription after an emergency
department visit versus not filling a prescription
was estimated to approximate the number of pa-
tients who would need to be prescribed an initial
opioid for one patient to become a long-term user.
A definition of “number needed to harm” is pro-
vided in the Methods section in the Supplemen-
tary Appendix.29
We performed additional sensitivity analyses
to address the possibility of selection bias and
sensitivity to design assumptions (details are pro-
vided in the Methods section in the Supplementary
Appendix). These analyses included an alternative
exposure in which intensity was defined accord-
ing to the median dose of opioid prescription filled
after an emergency department visit, as described
above. Replicating our results with an alternative
definition of exposure that operates through a
similar causal pathway (increased opioid exposure)
could argue against selection bias, particularly if
the two exposures (dose and frequency of opioid
prescribing) are minimally correlated.
All analyses were performed with the use of
Stata software, version 14.1 (StataCorp). The 95%
confidence intervals around reported estimates
reflect 0.025 in each tail, or P values no higher
than 0.05.
Results
Our sample consisted of 215,678 patients treated
by a low-intensity opioid prescriber and 161,951
patients treated by a high-intensity opioid pre-
scriber during an index emergency department
visit. Overall, the characteristics of patients treated
by high-intensity opioid prescribers were similar
to those of patients treated by low-intensity pre-
scribers, although several differences were signifi-
cant given the large sample size (Table 1). Diag-
noses in patients seen by high-intensity prescribers
and those seen by low-intensity prescribers were
similar (P = 0.87 by the Kolmogorov–Smirnov test
for differences in the distribution of 300 CCS
groups, according to prescriber group [Fig. S1 in
the Supplementary Appendix; for distribution of
the top 25 of 300 CCS diagnosis groups, according
to prescriber group, see Fig. S2 in the Supplemen-
tary Appendix]).
On average, rates of opioid prescribing between
low-intensity prescribers and high-intensity pre-
scribers varied by a factor of 3.3 within the same
hospital (7.3% vs. 24.1% of emergency department
visits, P0.001) (Table 2 and Fig. 1A). Across all
subgroups, prescribing rates among high-intensi-
ty prescribers were triple those among low-inten-
sity prescribers. The highest average rate was seen
among patients who visited the emergency de-
partment with an injury (23.7%) (Table 2). There
was minimal correlation between physicians’ pre-
scribing rates and the median initial dose of an
opioid prescription that was filled (r = −0.08) (Fig.
S3 and Table S1 in the Supplementary Appendix)
or type of opioid prescribed (Table S2 in the Sup-
plementary Appendix).
Overall, long-term opioid use at 12 months
was significantly higher among patients treated
by high-intensity prescribers than among patients
treated by low-intensity prescribers (1.51% vs.
1.16%; unadjusted odds ratio, 1.31; 95% confi-
dence interval [CI], 1.24 to 1.39) (Table 2 and
Fig. 2). After adjustment, there was minimal
change in this difference (adjusted odds ratio,
1.30; 95% CI, 1.23 to 1.37). This finding corre-
sponds to a number needed to harm of 48 pa-
tients receiving an opioid prescription to theo-
retically lead to 1 excess long-term opioid user.
We observed a stepwise increase in long-term
opioid use with exposure to physicians in each
quartile of opioid prescribing frequency. As com-
pared with the first (low-intensity) quartile, pa-
tients treated by physicians in the second quar-
tile had an adjusted odds ratio for long-term opioid
use of 1.10 (95% CI, 1.04 to 1.16) and patients
treated by physicians in the third quartile had an
adjusted odds ratio of 1.19 (95% CI, 1.12 to 1.25)
(Fig. 1B, and Table S3 in the Supplementary Ap-
pendix). Differences in long-term opioid use be-
tween patients treated by high-intensity prescribers
and those treated by low-intensity opioid prescrib-
ers were consistent across subgroups, with mini-
mal change after multivariable adjustment (Fig. 2).
Rates of opioid-related hospital encounters and
encounters for fall or fracture were significantly
higher in the 12 months after an index emergency
department visit among patients treated by high-
intensity opioid prescribers than among patients
treated by low-intensity opioid prescribers (rates of
any opioid-related encounter, 9.96% vs. 9.73%;
adjusted odds ratio, 1.03; 95% CI, 1.00 to 1.05;
P = 0.02; rates of encounters for fall or fracture,
4.56% vs. 4.28%; adjusted odds ratio, 1.07; 95% CI,
The New England Journal of Medicine
Downloaded from nejm.org on February 15, 2017. For personal use only. No other uses without permission.
Copyright © 2017 Massachusetts Medical Society. All rights reserved.
n engl j med 376;7 nejm.org  February 16, 2017668
The new engl and jour nal of medicine
Variable
Initial Rate of Opioid Prescription
in Emergency Department Rate of Long-Term Use
Average
Rate
Low-Intensity
Prescriber
High-Intensity
Prescriber
Low-Intensity
Prescriber
High-Intensity
Prescriber
percent
Overall rate of opioid prescribing 14.7 7.3 24.1 1.16 1.51
Rate of prescribing according to patient characteristic
Age
65 yr 17.9 8.8 28.9 2.09 2.82
65–74 yr 16.4 8.4 26.4 0.86 1.00
75–84 yr 12.3 6.0 20.4 0.68 0.89
≥85 yr 8.9 4.3 15.6 0.86 1.01
Sex
Male 15.1 7.6 24.7 1.22 1.53
Female 14.4 7.1 23.8 1.13 1.51
Race
White 14.6 7.5 23.7 1.16 1.50
Black 14.9 6.8 25.0 1.38 1.87
Medicare–Medicaid dual eligibility
No 14.4 7.4 23.4 0.71 0.87
Yes 15.0 7.2 24.8 1.62 2.17
No. of chronic conditions†
0 18.7 9.5 29.9 1.29 1.73
1 or 2 16.9 8.5 27.4 1.07 1.52
≥3 13.3 6.5 22.0 1.17 1.48
Alzheimer’s disease
No 15.9 8.0 25.9 1.15 1.52
Yes 8.5 4.0 14.7 1.19 1.49
Disabled
No 13.4 6.7 22.1 0.71 0.87
Yes 17.0 8.3 27.5 1.95 2.59
Depression
No 14.8 7.4 24.2 0.78 1.01
Yes 14.5 7.1 23.9 1.74 2.28
Census region
Northeast 11.9 5.2 20.5 0.78 1.11
Midwest 14.0 6.9 23.4 1.27 1.45
South 15.9 8.4 25.3 1.33 1.81
West 16.2 7.7 26.7 1.07 1.44
Emergency department visit for injury‡
No 13.7 6.7 22.7 1.16 1.53
Yes 23.7 12.6 35.8 1.14 1.42
*	Long-term opioid use was defined as 6 months of days of opioids supplied in the 12 months after an index emergency department visit,
­excluding the first 30 days after the index emergency department visit.
†	The number of chronic conditions among 11 possible conditions is shown. These conditions are the following: acute myocardial infarction,
Alzheimer’s dementia, atrial fibrillation, cerebrovascular disease, chronic kidney disease, chronic obstructive pulmonary disease, congestive
heart failure, depression, diabetes, hyperlipidemia, and hypertension.
‡	An emergency department visit for an injury was defined as any emergency department visit with an “E” code associated with an injury
­(according to the codes in the International Classification of Diseases, 9th Revision). Of patients who visited an emergency department for a
reason other than an injury, 195,651 saw low-intensity prescribers and 144,895 saw high-intensity prescribers. Of patients who visited an
emergency department because of an injury, 20,027 saw low-intensity prescribers and 17,056 saw high-intensity prescribers.
Table 2. Rate of Filling a Prescription for Opioids within 7 Days after Emergency Department Visit and Rate of Long-Term Use,
According to Opioid Prescribing Intensity of Physician Seen.*
The New England Journal of Medicine
Downloaded from nejm.org on February 15, 2017. For personal use only. No other uses without permission.
Copyright © 2017 Massachusetts Medical Society. All rights reserved.
n engl j med 376;7 nejm.org  February 16, 2017 669
Opioid Prescribing and Risk of Long-Term Use
1.03 to 1.11; P0.001) (Table 3). There was no
significant difference in 12-month rates of over-
all hospital encounters or non–opioid-related en-
counters. Assessment of rates of short-term emer-
gency department revisits for possible evidence
of undertreated pain showed that rates of 14-day
and 30-day repeat emergency department visits
with the same primary diagnosis as the index visit
were similar in the two prescriber groups (P0.07)
(Table S4 in the Supplementary Appendix).
We replicated the main analysis described above
in multiple other sensitivity analyses, including one
that used a propensity score–matched cohort (see
the Results section in the Supplementary Appen-
dix), although the finding of increased hospital
encounters for falls or fractures with the use of
propensity score matching (P = 0.05) and with the
use of CCS category fixed effects (P = 0.12) was
not significant (Table S6 in the Supplementary
Appendix). In analyses in which physicians were
categorized as being high or low “dose intensity”
prescribers, we found increased odds of long-term
opioid use among patients treated by high dose-
intensity prescribers (odds ratio, 1.32; 95% CI,
1.19 to 1.46) (Table S6 and Fig. S4 in the Supple-
mentary Appendix).
Discussion
In a large, national sample of patients enrolled in
Medicare Part D who received care in an emer-
gency department and who had not used prescrip-
tion opioids in the 6 months before the visit to
the emergency department, we found substantial
variation in the opioid prescribing patterns of
emergency physicians within the same hospital.
The intensity of a physician’s opioid prescribing
was positively associated with the probability that
a patient would become a long-term opioid user
over the subsequent 12 months. Although our
study was observational, we sought to minimize
selection bias by comparing the characteristics of
patients seen by different emergency physicians
within the same hospital. The association between
physician prescribing rates and increased long-
term opioid use was consistent across numerous
subgroups and across all quartiles of physician
prescribing in a dose–response pattern.
It is commonly thought that opioid dependence
often begins through an initial, possibly chance,
exposure to a physician-prescribed opioid, al-
though data from studies to empirically evaluate
this claim are lacking. Our results provide evi-
dence that this mechanism could drive initiation
of long-term opioid use through either increased
rates of opioid prescription or prescription of a
high, versus a low, dose of opioid. Although cau-
sality cannot be established from this observa-
Figure 1. Prescribing Rates and Adjusted Odds Ratios
for Long-Term Opioid Use, According to Quartile of
Physician Opioid Prescribing.
Panel A shows rates of opioid prescribing by emergen-
cy physicians according to within-hospital quartile.
I bars represent 95% confidence intervals. Panel B
shows the adjusted odds ratios and corresponding
95% confidence intervals for rates of long-term opioid
use, according to quartile of physician opioid prescrib-
ing. Physicians in each quartile were compared with
those in the lowest prescribing quartile. Odds ratios
were estimated with the use of logistic-regression
models.
PercentofEmergencyDepartment
VisitswithanOpioidPrescription
30
20
25
15
10
5
0
1 2 3 4
Prescriber Quartile
B
A
OddsRatioforLong-TermOpioidUse
1.4
1.2
1.3
1.1
1.0
1
(Low intensity,
reference)
2 3 4
(High
intensity)
Prescriber Quartile
The New England Journal of Medicine
Downloaded from nejm.org on February 15, 2017. For personal use only. No other uses without permission.
Copyright © 2017 Massachusetts Medical Society. All rights reserved.
n engl j med 376;7 nejm.org  February 16, 2017670
The new engl and jour nal of medicine
tional study, if our results represent a causal re-
lationship, for every 48 patients prescribed a new
opioid in the emergency department who might
not otherwise use opioids, 1 will become a long-
term user; this is a low number needed to harm
for such a common therapy.
Of course, prescriptions provided by other phy-
sicians in the months after an emergency depart-
ment visit are necessary for long-term opioid use
to take hold. Conversion to long-term use may be
driven partly by clinical “inertia” leading outpa-
tient clinicians to continue providing previous
prescriptions. Such clinical inertia may affect only
a narrow segment of the population; this could
explain why rates of initial opioid prescribing may
vary by a factor of three, whereas long-term use
varies by only approximately 30%. It is impor-
tant to acknowledge that patients treated by high-
Figure 2. Unadjusted and Adjusted Odds Ratios for Long-Term Opioid Use, According to Treatment by High-Intensity
or Low-Intensity Opioid Prescriber.
All unadjusted odds ratios were estimated with the use of bivariate logistic regression with the occurrence of long-
term opioid use as the dependent variable and exposure to a high-intensity provider as the key explanatory variable.
All adjusted models had further adjustment for the patients’ age, sex, race or ethnic group, Medicare–Medicaid
dual eligibility, and disability status and the presence of 11 chronic conditions.
1.2 1.6 2.0
Overall opioid use at 12 mo
Age
65 yr
65–74 yr
75–84 yr
≥85 yr
Sex
Male
Female
Race
White
Black
Census region
Northeast
Midwest
South
West
No. of chronic conditions
None
1 or 2
≥3
Medicare–Medicaid dual eligibility
No
Yes
Depression
No
Yes
Emergency department visit for injury
No
Yes
Alzheimer’s disease
No
Yes
Disabled
No
Yes
1.31
1.36
1.16
1.32
1.18
1.26
1.34
1.29
1.36
1.43
1.14
1.37
1.35
1.35
1.43
1.26
1.22
1.35
1.30
1.32
1.32
1.25
1.32
1.26
1.23
1.33
Unadjusted
Odds Ratio (95% CI)
Odds Ratio
Adjusted (95% CI)
Subgroup
1.26 (1.09–1.44)
1.34 (1.25–1.44)
1.25 (1.05–1.49)
1.31 (1.23–1.39)
1.30 (1.23–1.38)
1.30 (1.21–1.40)
1.20 (1.08–1.33)
1.34 (1.26–1.44)
1.29 (1.18–1.41)
1.24 (1.13–1.36)
1.41 (1.26–1.58)
1.36 (1.15–1.61)
1.25 (1.17–1.34)
1.34 (1.17–1.53)
1.12 (1.00–1.27)
1.42 (1.23–1.64)
1.35 (1.19–1.53)
1.36 (1.25–1.48)
1.28 (1.20–1.37)
1.25 (1.14–1.37)
1.33 (1.24–1.43)
1.18 (0.98–1.42)
1.33 (1.15–1.54)
1.17 (1.03–1.32)
1.30 (1.23–1.37)
0.8
1.37 (1.27–1.48)
The New England Journal of Medicine
Downloaded from nejm.org on February 15, 2017. For personal use only. No other uses without permission.
Copyright © 2017 Massachusetts Medical Society. All rights reserved.
n engl j med 376;7 nejm.org  February 16, 2017 671
Opioid Prescribing and Risk of Long-Term Use
intensity opioid prescribers may have dispropor-
tionately required appropriate opioid therapy,
although some of the variation we observed in
rates of opioid prescribing may also indicate over-
use. If differences in appropriate use were a major
driver of variation in prescribing, we may have
expected increased rates of short-term emergency
department revisits due to inadequately treated
pain among the low-intensity prescriber groups.
However, we did not find a difference in such rates
between prescriber groups; this suggests that in-
creased opioid prescribing did not prevent revis-
its to the emergency department.
Our results are unlikely to be explained by se-
lection bias for several reasons. First, our analysis
focused on variation in opioid prescribing of emer-
gency physicians within the same hospital; these
physicians are unlikely to select or attract system-
atically different patient populations. Second, even
though there were small differences in character-
istics between patients treated by the two pre-
scriber groups, adjustment for these characteris-
tics did not change our results with respect to
long-term opioid use. We also replicated our re-
sults in a range of sensitivity analyses, and the case
mix of emergency department visits across 300
diagnosis categories was statistically indistinguish-
able between groups. In addition, we replicated our
results with an alternative exposure definition
based on opioid dose; this exposure was mini-
mally correlated with the frequency of opioid pre-
scribing by physicians.
Our study has several limitations. Most impor-
tant, this is an observational study and cannot be
interpreted as causal, although our findings were
robust in several sensitivity analyses addressing
selection bias. Second, since we could not ob-
serve whether an opioid prescription was appro-
Type of Hospital Encounter 12-Mo Encounter Rate
Adjusted Odds Ratio
(95% CI)† P Value†
Patients Treated
by Low-Intensity
Prescriber
(N = 215,678)
Patients Treated
by High-Intensity
Prescriber
(N = 161,951)
% of patients
Any hospital encounter 60.5 60.3 0.99 (0.97–1.00) 0.13
Any hospitalization 46.1 45.8 0.99 (0.97–1.00) 0.15
Any emergency department visit 57.4 57.1 0.99 (0.97–1.00) 0.07
Any opioid-related hospital encounter 9.73 9.96 1.03 (1.00–1.05) 0.02
Fall or fracture 4.28 4.56 1.07 (1.03–1.11) 0.001
Constipation 4.16 4.11 0.99 (0.96–1.02) 0.44
Respiratory failure 2.04 2.01 0.98 (0.94–1.03) 0.46
Opioid poisoning 0.07 0.10 1.40 (1.12–1.74) 0.001
Any selected non–opioid-related
hospital encounter
11.77 11.75 1.00 (0.98–1.02) 0.85
Hyperglycemia 0.24 0.24 0.99 (0.87–1.14) 0.93
Urinary tract infection 1.08 1.13 1.04 (0.98–1.11) 0.17
Atrial fibrillation 6.48 6.39 0.98 (0.95–1.01) 0.24
Stroke 4.12 4.08 0.99 (0.96–1.02) 0.52
*	A hospital encounter refers to a hospitalization or an emergency department visit. Definitions are provided in the
Methods section in the Supplementary Appendix. CI denotes confidence interval.
†	Adjusted odds ratios and P values were estimated with the use of logistic-regression models with occurrence of an opi-
oid-related hospitalization in the 12 months after an emergency department visit as the dependent variable. The key co-
variate was an indicator for being seen by a high-intensity or a low-intensity prescriber. All models were adjusted for
age, sex, race and ethnic group, Medicare–Medicaid dual eligibility, and the presence of 11 chronic conditions.
Table 3. Hospital Encounters within 12 Months after an Index Emergency Department Visit to a Low-Intensity or High-
Intensity Opioid Prescriber.*
The New England Journal of Medicine
Downloaded from nejm.org on February 15, 2017. For personal use only. No other uses without permission.
Copyright © 2017 Massachusetts Medical Society. All rights reserved.
n engl j med 376;7 nejm.org  February 16, 2017672
The new engl and jour nal of medicine
priate, our ability to quantify the extent of over-
use of opioids was limited. Third, because we
focused on Medicare patients with Part D enroll-
ment and emergency department visits, our re-
sults may not be generalizable to other popula-
tions. However, the growing prevalence of opioid
misuse among the elderly makes this an impor-
tant group to study.16,24
Fourth, the association
between high-intensity opioid prescribers and opi-
oid-related hospital encounters within 12 months
after the index emergency department visit was
small and not significant in some sensitivity analy-
ses. In addition, for outcomes with a significant
association, the absolute difference in rates of
hospital encounters between groups was small
(e.g., an absolute difference of 0.23 percentage
points for any opioid-related encounter) (Table 3).
Therefore, we have weaker evidence to support
this association than our results on long-term opi-
oid use, and if it were causal, the clinical magni-
tude of this association would be small. Fifth,
we were unable to unequivocally attribute an
opioid prescription to an emergency physician;
however, our analyses were robust with respect
to a stricter threshold of 3 days to fill a prescrip-
tion for opioids from an emergency physician.16
Finally, our statistical tests do not account for the
false positive rate associated with multiple second-
ary analyses; therefore, P values should be regard-
ed as exploratory.
In conclusion, we found variation by a factor
of more than three in rates of opioid prescribing
by emergency physicians within the same hospital
and increased rates of long-term opioid use among
patients treated by high-intensity opioid prescrib-
ers. These results suggest that an increased likeli-
hood of receiving an opioid for even one encounter
could drive clinically significant future long-term
opioid use and potentially increased adverse out-
comes among the elderly. Future research may
explore whether this variation reflects overpre-
scription by some prescribers and whether it is
amenable to intervention.
Supported by a grant from the Office of the Director, Na-
tional Institutes of Health (NIH) (NIH Director’s Early Indepen-
dence Award, 1DP5OD017897-01, to Dr. Jena).
Dr. Barnett reports serving as medical advisor to and holding
stock in Ginger.io; and Dr. Jena, receiving consulting fees from
Pfizer, Hill-Rom Services, Bristol-Myers Squibb, Novartis Phar-
maceuticals, Vertex Pharmaceuticals, and Precision Health Eco-
nomics. No other potential conflict of interest relevant to this
article was reported.
Disclosure forms provided by the authors are available with
the full text of this article at NEJM.org.
References
1.	 Vital signs:​overdoses of prescription
opioid pain relievers — United States,
1999–2008. MMWR Morb Mortal Wkly
Rep 2011;​60:​1487-2.
2.	 Prescription opioid overdose data. At-
lanta:​Centers for Disease Control and
Prevention, 2016 (http://www​.cdc​.gov/​
drugoverdose/​data/​overdose​.html).
3.	 National Institute on Drug Abuse.
America’s addiction to opioids:​heroin and
prescription drug abuse. May 14, 2014
(https:/​/​www​.drugabuse​.gov/​about-nida/​
legislative-activities/​testimony-to
-congress/​2016/​americas-addiction-to
-opioids-heroin-prescription-drug-abuse).
4.	 Healthcare Cost and Utilization Proj-
ect. Hospital inpatient utilization related
to opioid overuse among adults, 1993-
2012. August 2014 (https:/​/​www​.hcup-us​
.ahrq​.gov/​reports/​statbriefs/​sb177
-Hospitalizations-for-Opioid-Overuse​.jsp).
5.	 Vestal C. Older addicts squeezed by
opioid epidemic. Stateline. July 26, 2016
(http://pew​.org/​2asv3TO).
6.	 Dufour R, Joshi AV, Pasquale MK, et
al. The prevalence of diagnosed opioid
abuse in commercial and Medicare man-
aged care populations. Pain Pract 2014;​
14(3):​E106-E115.
7.	 Makris UE, Abrams RC, Gurland B,
Reid MC. Management of persistent pain
in the older patient: a clinical review.
JAMA 2014;​312:​825-36.
8.	 Miller M, Stürmer T, Azrael D, Levin
R, Solomon DH. Opioid analgesics and
the risk of fractures in older adults with
arthritis. J Am Geriatr Soc 2011;​59:​430-8.
9.	 Solomon DH, Rassen JA, Glynn RJ,
Lee J, Levin R, Schneeweiss S. The com-
parative safety of analgesics in older
adults with arthritis. Arch Intern Med
2010;​170:​1968-76.
10.	Buckeridge D, Huang A, Hanley J, et
al. Risk of injury associated with opioid
use in older adults. J Am Geriatr Soc 2010;​
58:​1664-70.
11.	 O’Neil CK, Hanlon JT, Marcum ZA. Ad-
verse effects of analgesics commonly used
by older adults with osteoarthritis: focus on
non-opioid and opioid analgesics. Am J
Geriatr Pharmacother 2012;​10:​331-42.
12.	Butler MM, Ancona RM, Beauchamp
GA, et al. Emergency department pre-
scription opioids as an initial exposure
preceding addiction. Ann Emerg Med
2016;​68:​202-8.
13.	Frank R. Targeting the opioid drug
crisis:​a Health and Human Services ini-
tiative. Health Affairs Blog. April 3, 2015
(http://healthaffairs​.org/​blog/​2015/​04/​03/​
targeting-the-opioid-drug-crisis-a-health
-and-human-services-initiative/​).
14.	Department of Health and Human
Services Behavioral Health Coordinating
Committee. Addressing prescription drug
abuse in the United States: current activi-
ties and future opportunities. 2014 (https:/​/​
www​.cdc​.gov/​drugoverdose/​pdf/​hhs
_prescription_drug_abuse_report_09​
.2013​.pdf).
15.	Kuo Y-F, Raji MA, Chen N-W, Hasan
H, Goodwin JS. Trends in opioid prescrip-
tions among Part D Medicare recipients
from 2007 to 2012. Am J Med 2016;​129(2):​
221.e21-221.e30.
16.	Jena AB, Goldman D, Karaca-Mandic
P. Hospital prescribing of opioids to
Medicare beneficiaries. JAMA Intern Med
2016;​176:​990-7.
17.	Poon SJ, Greenwood-Ericksen MB.
The opioid prescription epidemic and the
role of emergency medicine. Ann Emerg
Med 2014;​64:​490-5.
18.	Tamayo-Sarver JH, Dawson NV, Cy-
dulka RK, Wigton RS, Baker DW. Vari-
ability in emergency physician decision
making about prescribing opioid analge-
sics. Ann Emerg Med 2004;​43:​483-93.
19.	Pletcher MJ, Kertesz SG, Kohn MA,
Gonzales R. Trends in opioid prescribing
The New England Journal of Medicine
Downloaded from nejm.org on February 15, 2017. For personal use only. No other uses without permission.
Copyright © 2017 Massachusetts Medical Society. All rights reserved.
n engl j med 376;7 nejm.org  February 16, 2017 673
Opioid Prescribing and Risk of Long-Term Use
by race/ethnicity for patients seeking care
in US emergency departments. JAMA
2008;​299:​70-8.
20.	 Hoppe JA, Nelson LS, Perrone J, Wein-
er SG. Opioid prescribing in a cross sec-
tion of US emergency departments. Ann
Emerg Med 2015;​66(3):​253-259.e1.
21.	Dowell D, Haegerich TM, Chou R.
CDC guideline for prescribing opioids for
chronic pain — United States, 2016.
JAMA 2016;​315:​1624-45.
22.	Dunn KM, Saunders KW, Rutter CM,
et al. Opioid prescriptions for chronic
pain and overdose: a cohort study. Ann
Intern Med 2010;​152:​85-92.
23.	Braden JB, Russo J, Fan M-Y, et al.
Emergency department visits among re-
cipients of chronic opioid therapy. Arch
Intern Med 2010;​170:​1425-32.
24.	 Jena AB, Goldman D, Weaver L, Kara-
ca-Mandic P. Opioid prescribing by mul-
tiple providers in Medicare: retrospective
observational study of insurance claims.
BMJ 2014;​348:​g1393.
25.	Healthcare Cost and Utilization Proj-
ect. Clinical Classifications Software (CCS)
for ICD-9-CM (https:/​/​www​.hcup-us​.ahrq​
.gov/​toolssoftware/​ccs/​ccs​.jsp).
26.	Meara E, Horwitz JR, Powell W, et al.
State legal restrictions and prescription-
opioid use among disabled adults. N Engl
J Med 2016;​375:​44-53.
27.	National Institute of Standards and
Technology. Kolmogorov-Smirnov Good-
ness-of-Fit Test. 2013 (http://www​.itl​.nist​
.gov/​div898/​handbook/​eda/​section3/​
eda35g​.htm).
28.	White H. A heteroskedasticity-consis-
tent covariance matrix and a direct test for
heteroskedasticity. Econometrica 1980;​48:​
817-38.
29.	Angrist JD, Pischke J-S. Mostly harm-
less econometrics: an empiricist’s com-
panion. Princeton, NJ:​Princeton Univer-
sity Press, 2008.
Copyright © 2017 Massachusetts Medical Society.
Tiger, Kanha National Park, India	 Anil Sain, M.D.
The New England Journal of Medicine
Downloaded from nejm.org on February 15, 2017. For personal use only. No other uses without permission.
Copyright © 2017 Massachusetts Medical Society. All rights reserved.

Contenu connexe

Tendances

Incident opioid abuse and dependence sullivan 2014
Incident opioid abuse and dependence sullivan 2014Incident opioid abuse and dependence sullivan 2014
Incident opioid abuse and dependence sullivan 2014
Paul Coelho, MD
 
Genoa Pharmacy Med adherence & outcomes study
Genoa Pharmacy Med adherence & outcomes studyGenoa Pharmacy Med adherence & outcomes study
Genoa Pharmacy Med adherence & outcomes study
John Muilenburg
 

Tendances (16)

Harm reduction on a large scale
Harm reduction on a large scaleHarm reduction on a large scale
Harm reduction on a large scale
 
Rita Nieves, "Boston Public Health Commission: A City's Health Department Per...
Rita Nieves, "Boston Public Health Commission: A City's Health Department Per...Rita Nieves, "Boston Public Health Commission: A City's Health Department Per...
Rita Nieves, "Boston Public Health Commission: A City's Health Department Per...
 
Benzodiazepine use in the united states
Benzodiazepine use in the united statesBenzodiazepine use in the united states
Benzodiazepine use in the united states
 
aidslinedec13
aidslinedec13aidslinedec13
aidslinedec13
 
Emergency med pharmacist 2017 coralic a. et al
Emergency med pharmacist 2017 coralic a. et alEmergency med pharmacist 2017 coralic a. et al
Emergency med pharmacist 2017 coralic a. et al
 
Cost burdenofchronic pain
Cost burdenofchronic painCost burdenofchronic pain
Cost burdenofchronic pain
 
Phenobarbarbital for Benzo Withdrawal
Phenobarbarbital for Benzo WithdrawalPhenobarbarbital for Benzo Withdrawal
Phenobarbarbital for Benzo Withdrawal
 
Incident opioid abuse and dependence sullivan 2014
Incident opioid abuse and dependence sullivan 2014Incident opioid abuse and dependence sullivan 2014
Incident opioid abuse and dependence sullivan 2014
 
Barriers to bup among rural physicians
Barriers to bup among rural physiciansBarriers to bup among rural physicians
Barriers to bup among rural physicians
 
Genoa Pharmacy Med adherence & outcomes study
Genoa Pharmacy Med adherence & outcomes studyGenoa Pharmacy Med adherence & outcomes study
Genoa Pharmacy Med adherence & outcomes study
 
Pain Validity Test identifies drug seeking behavior. Stop opioid abuse. Prote...
Pain Validity Test identifies drug seeking behavior. Stop opioid abuse. Prote...Pain Validity Test identifies drug seeking behavior. Stop opioid abuse. Prote...
Pain Validity Test identifies drug seeking behavior. Stop opioid abuse. Prote...
 
Warfarin vitamin k_patel_2008
Warfarin vitamin k_patel_2008Warfarin vitamin k_patel_2008
Warfarin vitamin k_patel_2008
 
Expanding the Understanding of Risks Associated with Opioids as Well as Strat...
Expanding the Understanding of Risks Associated with Opioids as Well as Strat...Expanding the Understanding of Risks Associated with Opioids as Well as Strat...
Expanding the Understanding of Risks Associated with Opioids as Well as Strat...
 
Tx 3 hill shuman_oliver
Tx 3 hill shuman_oliverTx 3 hill shuman_oliver
Tx 3 hill shuman_oliver
 
Naloxone for Opioid Safety by Phillip Coffin, MD, MIA
Naloxone for Opioid Safety by Phillip Coffin, MD, MIANaloxone for Opioid Safety by Phillip Coffin, MD, MIA
Naloxone for Opioid Safety by Phillip Coffin, MD, MIA
 
Twillman preventing rx abuse
Twillman preventing rx abuseTwillman preventing rx abuse
Twillman preventing rx abuse
 

En vedette

PASI Poster OPEN Template
PASI Poster OPEN TemplatePASI Poster OPEN Template
PASI Poster OPEN Template
Thomas Huang
 
Lane ePrescribe
Lane ePrescribeLane ePrescribe
Lane ePrescribe
TORC
 
Herramientas de windows y sus aplicaciones
Herramientas de windows y sus aplicacionesHerramientas de windows y sus aplicaciones
Herramientas de windows y sus aplicaciones
BENJAMINGALLEGOSLOPEZ
 

En vedette (20)

PASI Poster OPEN Template
PASI Poster OPEN TemplatePASI Poster OPEN Template
PASI Poster OPEN Template
 
Lane ePrescribe
Lane ePrescribeLane ePrescribe
Lane ePrescribe
 
Rx15 pdmp wed_1115_1_kreiner_2ringwalt
Rx15 pdmp wed_1115_1_kreiner_2ringwaltRx15 pdmp wed_1115_1_kreiner_2ringwalt
Rx15 pdmp wed_1115_1_kreiner_2ringwalt
 
instalacion de ubuntu
instalacion de ubuntuinstalacion de ubuntu
instalacion de ubuntu
 
КАК СДЕЛАТЬ ПРЕЗЕНТАЦИЮ К ДИПЛОМУ
КАК СДЕЛАТЬ ПРЕЗЕНТАЦИЮ К ДИПЛОМУКАК СДЕЛАТЬ ПРЕЗЕНТАЦИЮ К ДИПЛОМУ
КАК СДЕЛАТЬ ПРЕЗЕНТАЦИЮ К ДИПЛОМУ
 
America
AmericaAmerica
America
 
Herramientas de windows y sus aplicaciones
Herramientas de windows y sus aplicacionesHerramientas de windows y sus aplicaciones
Herramientas de windows y sus aplicaciones
 
Case study marki ŻYWIEC z Albumu Superbrands Polska 2008
Case study marki ŻYWIEC z Albumu Superbrands Polska 2008Case study marki ŻYWIEC z Albumu Superbrands Polska 2008
Case study marki ŻYWIEC z Albumu Superbrands Polska 2008
 
Gym Star (1)
Gym Star (1)Gym Star (1)
Gym Star (1)
 
Dajjal the False Messiah
Dajjal the False MessiahDajjal the False Messiah
Dajjal the False Messiah
 
Humorweaning
HumorweaningHumorweaning
Humorweaning
 
C&S Electric Summer Training Report
C&S Electric Summer Training ReportC&S Electric Summer Training Report
C&S Electric Summer Training Report
 
Interactive media booklet
Interactive media bookletInteractive media booklet
Interactive media booklet
 
My CV
My CVMy CV
My CV
 
Σύγχρονο χρήμα
Σύγχρονο χρήμα Σύγχρονο χρήμα
Σύγχρονο χρήμα
 
ePrescribe Controlled Substances With Ease
ePrescribe Controlled Substances With EaseePrescribe Controlled Substances With Ease
ePrescribe Controlled Substances With Ease
 
Pharmacy – Requirements, Standards, Architecture & Implementation
Pharmacy – Requirements, Standards, Architecture & ImplementationPharmacy – Requirements, Standards, Architecture & Implementation
Pharmacy – Requirements, Standards, Architecture & Implementation
 
Funny or Sad
Funny or SadFunny or Sad
Funny or Sad
 
National drug policy of Nepal
National drug policy of NepalNational drug policy of Nepal
National drug policy of Nepal
 
Fackler Grand Rounds - 2016 CDC Opioid Guideline
Fackler Grand Rounds - 2016 CDC Opioid GuidelineFackler Grand Rounds - 2016 CDC Opioid Guideline
Fackler Grand Rounds - 2016 CDC Opioid Guideline
 

Similaire à High Intensity Prescribers in the ED

Prescription opioid use among adults with mental health disorders in the US.
Prescription opioid use among adults with mental health disorders in the US.Prescription opioid use among adults with mental health disorders in the US.
Prescription opioid use among adults with mental health disorders in the US.
Paul Coelho, MD
 
Prescription Opioid Use Among Adults with Mental Health Disorders in the US
Prescription Opioid Use Among Adults with Mental Health Disorders in the USPrescription Opioid Use Among Adults with Mental Health Disorders in the US
Prescription Opioid Use Among Adults with Mental Health Disorders in the US
Paul Coelho, MD
 
Prescriptions filled following an opioid-related hospitalization.
Prescriptions filled following an opioid-related hospitalization.Prescriptions filled following an opioid-related hospitalization.
Prescriptions filled following an opioid-related hospitalization.
Paul Coelho, MD
 
Pain Med 2015 - Westanmo - Opioid Dose Reduction in a VA Health Care
Pain Med 2015 - Westanmo - Opioid Dose Reduction in a VA Health CarePain Med 2015 - Westanmo - Opioid Dose Reduction in a VA Health Care
Pain Med 2015 - Westanmo - Opioid Dose Reduction in a VA Health Care
Peter Marshall, MD
 
Medical care responding_to_us_opioid_epidemic_von_korff_franklin_4-22-2016 (3)
Medical care responding_to_us_opioid_epidemic_von_korff_franklin_4-22-2016 (3)Medical care responding_to_us_opioid_epidemic_von_korff_franklin_4-22-2016 (3)
Medical care responding_to_us_opioid_epidemic_von_korff_franklin_4-22-2016 (3)
Paul Coelho, MD
 
More Predictive Modeling of Total Healthcare Costs Using Pharmacy Claims Data
More Predictive Modeling of Total Healthcare Costs Using Pharmacy Claims DataMore Predictive Modeling of Total Healthcare Costs Using Pharmacy Claims Data
More Predictive Modeling of Total Healthcare Costs Using Pharmacy Claims Data
M. Christopher Roebuck
 

Similaire à High Intensity Prescribers in the ED (20)

Incident opioid abuse and dependence sullivan 2014 (2)
Incident opioid abuse and dependence sullivan 2014 (2)Incident opioid abuse and dependence sullivan 2014 (2)
Incident opioid abuse and dependence sullivan 2014 (2)
 
New study supports notion of skewed opioid prescribing
New study supports notion of skewed opioid prescribingNew study supports notion of skewed opioid prescribing
New study supports notion of skewed opioid prescribing
 
Physician Dispensing
Physician DispensingPhysician Dispensing
Physician Dispensing
 
Patterns of Opioid Use and Risk of Opioid Overdose Death Among Medicaid Patients
Patterns of Opioid Use and Risk of Opioid Overdose Death Among Medicaid PatientsPatterns of Opioid Use and Risk of Opioid Overdose Death Among Medicaid Patients
Patterns of Opioid Use and Risk of Opioid Overdose Death Among Medicaid Patients
 
Dose Escalations In the First Year For CNP = Aberrancy
Dose Escalations In the First Year For CNP = AberrancyDose Escalations In the First Year For CNP = Aberrancy
Dose Escalations In the First Year For CNP = Aberrancy
 
Prescription opioid use among adults with mental health disorders in the US.
Prescription opioid use among adults with mental health disorders in the US.Prescription opioid use among adults with mental health disorders in the US.
Prescription opioid use among adults with mental health disorders in the US.
 
Prescription Opioid Use Among Adults with Mental Health Disorders in the US
Prescription Opioid Use Among Adults with Mental Health Disorders in the USPrescription Opioid Use Among Adults with Mental Health Disorders in the US
Prescription Opioid Use Among Adults with Mental Health Disorders in the US
 
Cost burden of chronic pain
Cost burden of chronic painCost burden of chronic pain
Cost burden of chronic pain
 
Prescriptions filled following an opioid-related hospitalization.
Prescriptions filled following an opioid-related hospitalization.Prescriptions filled following an opioid-related hospitalization.
Prescriptions filled following an opioid-related hospitalization.
 
SSDI & Opioid Use
SSDI & Opioid UseSSDI & Opioid Use
SSDI & Opioid Use
 
Rx16 clinical wed_1230_1_shanehsaz_2waller
Rx16 clinical wed_1230_1_shanehsaz_2wallerRx16 clinical wed_1230_1_shanehsaz_2waller
Rx16 clinical wed_1230_1_shanehsaz_2waller
 
Opioid Reduction In The VA
Opioid Reduction In The VAOpioid Reduction In The VA
Opioid Reduction In The VA
 
Pain Med 2015 - Westanmo - Opioid Dose Reduction in a VA Health Care
Pain Med 2015 - Westanmo - Opioid Dose Reduction in a VA Health CarePain Med 2015 - Westanmo - Opioid Dose Reduction in a VA Health Care
Pain Med 2015 - Westanmo - Opioid Dose Reduction in a VA Health Care
 
Changes in Provider Prescribing Patterns After Implementation of an Emergency...
Changes in Provider Prescribing Patterns After Implementation of an Emergency...Changes in Provider Prescribing Patterns After Implementation of an Emergency...
Changes in Provider Prescribing Patterns After Implementation of an Emergency...
 
Gordon Postgrad Med 2014 159-66
Gordon Postgrad Med 2014 159-66Gordon Postgrad Med 2014 159-66
Gordon Postgrad Med 2014 159-66
 
Medical care responding_to_us_opioid_epidemic_von_korff_franklin_4-22-2016 (3)
Medical care responding_to_us_opioid_epidemic_von_korff_franklin_4-22-2016 (3)Medical care responding_to_us_opioid_epidemic_von_korff_franklin_4-22-2016 (3)
Medical care responding_to_us_opioid_epidemic_von_korff_franklin_4-22-2016 (3)
 
Iatrogenic Addiction Epidemic
Iatrogenic Addiction EpidemicIatrogenic Addiction Epidemic
Iatrogenic Addiction Epidemic
 
More Predictive Modeling of Total Healthcare Costs Using Pharmacy Claims Data
More Predictive Modeling of Total Healthcare Costs Using Pharmacy Claims DataMore Predictive Modeling of Total Healthcare Costs Using Pharmacy Claims Data
More Predictive Modeling of Total Healthcare Costs Using Pharmacy Claims Data
 
TRENDS AND PATTERNS OF GEOGRAPHIC VARIATIONS IN OPIOID PRESCRIBING
TRENDS AND PATTERNS OF GEOGRAPHIC VARIATIONS IN OPIOID PRESCRIBINGTRENDS AND PATTERNS OF GEOGRAPHIC VARIATIONS IN OPIOID PRESCRIBING
TRENDS AND PATTERNS OF GEOGRAPHIC VARIATIONS IN OPIOID PRESCRIBING
 
Enabling clinical trial expansion
Enabling clinical trial expansionEnabling clinical trial expansion
Enabling clinical trial expansion
 

Plus de Paul Coelho, MD

Mortality quadrupled among opioid-driven hospitalizations notably within lowe...
Mortality quadrupled among opioid-driven hospitalizations notably within lowe...Mortality quadrupled among opioid-driven hospitalizations notably within lowe...
Mortality quadrupled among opioid-driven hospitalizations notably within lowe...
Paul Coelho, MD
 
Correlation of opioid mortality with prescriptions and social determinants -a...
Correlation of opioid mortality with prescriptions and social determinants -a...Correlation of opioid mortality with prescriptions and social determinants -a...
Correlation of opioid mortality with prescriptions and social determinants -a...
Paul Coelho, MD
 
Opioids for the Treatment of Chronic Pain: Mistakes Made, Lessons Learned, an...
Opioids for the Treatment of Chronic Pain: Mistakes Made, Lessons Learned, an...Opioids for the Treatment of Chronic Pain: Mistakes Made, Lessons Learned, an...
Opioids for the Treatment of Chronic Pain: Mistakes Made, Lessons Learned, an...
Paul Coelho, MD
 
The conundrum of opioid tapering in long term opioid therapy for chronic pain...
The conundrum of opioid tapering in long term opioid therapy for chronic pain...The conundrum of opioid tapering in long term opioid therapy for chronic pain...
The conundrum of opioid tapering in long term opioid therapy for chronic pain...
Paul Coelho, MD
 

Plus de Paul Coelho, MD (20)

Suicidality Poster References.docx
Suicidality Poster References.docxSuicidality Poster References.docx
Suicidality Poster References.docx
 
Opioid Milli-equivalence Conversion Factors CDC
Opioid Milli-equivalence Conversion Factors CDCOpioid Milli-equivalence Conversion Factors CDC
Opioid Milli-equivalence Conversion Factors CDC
 
Labeling Woefulness: The Social Construction of Fibromyalgia
Labeling Woefulness: The Social Construction of FibromyalgiaLabeling Woefulness: The Social Construction of Fibromyalgia
Labeling Woefulness: The Social Construction of Fibromyalgia
 
Outcomes in Long-term Opioid Tapering and Buprenorphine Transition: A Retrosp...
Outcomes in Long-term Opioid Tapering and Buprenorphine Transition: A Retrosp...Outcomes in Long-term Opioid Tapering and Buprenorphine Transition: A Retrosp...
Outcomes in Long-term Opioid Tapering and Buprenorphine Transition: A Retrosp...
 
Pain Phenotyping Tool For Primary Care
Pain Phenotyping Tool For Primary CarePain Phenotyping Tool For Primary Care
Pain Phenotyping Tool For Primary Care
 
Fibromyalgia & Somatic Symptom Disorder Patient Handout
Fibromyalgia & Somatic Symptom Disorder Patient HandoutFibromyalgia & Somatic Symptom Disorder Patient Handout
Fibromyalgia & Somatic Symptom Disorder Patient Handout
 
Community Catastrophizing
Community CatastrophizingCommunity Catastrophizing
Community Catastrophizing
 
Risk-Benefit High-Dose LTOT
Risk-Benefit High-Dose LTOTRisk-Benefit High-Dose LTOT
Risk-Benefit High-Dose LTOT
 
Space Trial
Space TrialSpace Trial
Space Trial
 
Mortality quadrupled among opioid-driven hospitalizations notably within lowe...
Mortality quadrupled among opioid-driven hospitalizations notably within lowe...Mortality quadrupled among opioid-driven hospitalizations notably within lowe...
Mortality quadrupled among opioid-driven hospitalizations notably within lowe...
 
Jamapsychiatry santavirta 2017_oi_170084
Jamapsychiatry santavirta 2017_oi_170084Jamapsychiatry santavirta 2017_oi_170084
Jamapsychiatry santavirta 2017_oi_170084
 
Correlation of opioid mortality with prescriptions and social determinants -a...
Correlation of opioid mortality with prescriptions and social determinants -a...Correlation of opioid mortality with prescriptions and social determinants -a...
Correlation of opioid mortality with prescriptions and social determinants -a...
 
Gao recommendations to CMS
Gao recommendations to CMSGao recommendations to CMS
Gao recommendations to CMS
 
Prescribing by specialty
Prescribing by specialtyPrescribing by specialty
Prescribing by specialty
 
The place-of-antipsychotics-in-the-therapy-of-anxiety-disorders-and-obsessive...
The place-of-antipsychotics-in-the-therapy-of-anxiety-disorders-and-obsessive...The place-of-antipsychotics-in-the-therapy-of-anxiety-disorders-and-obsessive...
The place-of-antipsychotics-in-the-therapy-of-anxiety-disorders-and-obsessive...
 
Structured opioid refill clinic epic smartphrases
Structured opioid refill clinic epic smartphrases Structured opioid refill clinic epic smartphrases
Structured opioid refill clinic epic smartphrases
 
Opioids for the Treatment of Chronic Pain: Mistakes Made, Lessons Learned, an...
Opioids for the Treatment of Chronic Pain: Mistakes Made, Lessons Learned, an...Opioids for the Treatment of Chronic Pain: Mistakes Made, Lessons Learned, an...
Opioids for the Treatment of Chronic Pain: Mistakes Made, Lessons Learned, an...
 
The potential adverse influence of physicians’ words.
The potential adverse influence of physicians’ words.The potential adverse influence of physicians’ words.
The potential adverse influence of physicians’ words.
 
Ctaf chronic pain__evidence_report_100417
Ctaf chronic pain__evidence_report_100417Ctaf chronic pain__evidence_report_100417
Ctaf chronic pain__evidence_report_100417
 
The conundrum of opioid tapering in long term opioid therapy for chronic pain...
The conundrum of opioid tapering in long term opioid therapy for chronic pain...The conundrum of opioid tapering in long term opioid therapy for chronic pain...
The conundrum of opioid tapering in long term opioid therapy for chronic pain...
 

Dernier

Gorgeous Call Girls In Pune {9xx000xx09} ❤️VVIP ANKITA Call Girl in Pune Maha...
Gorgeous Call Girls In Pune {9xx000xx09} ❤️VVIP ANKITA Call Girl in Pune Maha...Gorgeous Call Girls In Pune {9xx000xx09} ❤️VVIP ANKITA Call Girl in Pune Maha...
Gorgeous Call Girls In Pune {9xx000xx09} ❤️VVIP ANKITA Call Girl in Pune Maha...
Sheetaleventcompany
 
science quiz bee questions.doc FOR ELEMENTARY SCIENCE
science quiz bee questions.doc FOR ELEMENTARY SCIENCEscience quiz bee questions.doc FOR ELEMENTARY SCIENCE
science quiz bee questions.doc FOR ELEMENTARY SCIENCE
maricelsampaga
 
❤️ Chandigarh Call Girls Service☎️9878799926☎️ Call Girl service in Chandigar...
❤️ Chandigarh Call Girls Service☎️9878799926☎️ Call Girl service in Chandigar...❤️ Chandigarh Call Girls Service☎️9878799926☎️ Call Girl service in Chandigar...
❤️ Chandigarh Call Girls Service☎️9878799926☎️ Call Girl service in Chandigar...
daljeetkaur2026
 
Delhi Call Girl Service 📞8650700400📞Just Call Divya📲 Call Girl In Delhi No💰Ad...
Delhi Call Girl Service 📞8650700400📞Just Call Divya📲 Call Girl In Delhi No💰Ad...Delhi Call Girl Service 📞8650700400📞Just Call Divya📲 Call Girl In Delhi No💰Ad...
Delhi Call Girl Service 📞8650700400📞Just Call Divya📲 Call Girl In Delhi No💰Ad...
Sheetaleventcompany
 
🍑👄Ludhiana Escorts Service☎️98157-77685🍑👄 Call Girl service in Ludhiana☎️Ludh...
🍑👄Ludhiana Escorts Service☎️98157-77685🍑👄 Call Girl service in Ludhiana☎️Ludh...🍑👄Ludhiana Escorts Service☎️98157-77685🍑👄 Call Girl service in Ludhiana☎️Ludh...
🍑👄Ludhiana Escorts Service☎️98157-77685🍑👄 Call Girl service in Ludhiana☎️Ludh...
dilpreetentertainmen
 
Top 20 Famous Indian Female Pornstars Name List 2024
Top 20 Famous Indian Female Pornstars Name List 2024Top 20 Famous Indian Female Pornstars Name List 2024
Top 20 Famous Indian Female Pornstars Name List 2024
Sheetaleventcompany
 
Low Rate Call Girls Jaipur {9521753030} ❤️VVIP NISHA CCall Girls in Jaipur Es...
Low Rate Call Girls Jaipur {9521753030} ❤️VVIP NISHA CCall Girls in Jaipur Es...Low Rate Call Girls Jaipur {9521753030} ❤️VVIP NISHA CCall Girls in Jaipur Es...
Low Rate Call Girls Jaipur {9521753030} ❤️VVIP NISHA CCall Girls in Jaipur Es...
Sheetaleventcompany
 
Erotic Call Girls Bangalore {7304373326} ❤️VVIP SIYA Call Girls in Bangalore ...
Erotic Call Girls Bangalore {7304373326} ❤️VVIP SIYA Call Girls in Bangalore ...Erotic Call Girls Bangalore {7304373326} ❤️VVIP SIYA Call Girls in Bangalore ...
Erotic Call Girls Bangalore {7304373326} ❤️VVIP SIYA Call Girls in Bangalore ...
Sheetaleventcompany
 
Call Girl Service In Mumbai ❤️🍑 9xx000xx09 👄🫦Independent Escort Service Mumba...
Call Girl Service In Mumbai ❤️🍑 9xx000xx09 👄🫦Independent Escort Service Mumba...Call Girl Service In Mumbai ❤️🍑 9xx000xx09 👄🫦Independent Escort Service Mumba...
Call Girl Service In Mumbai ❤️🍑 9xx000xx09 👄🫦Independent Escort Service Mumba...
Sheetaleventcompany
 

Dernier (20)

Gorgeous Call Girls In Pune {9xx000xx09} ❤️VVIP ANKITA Call Girl in Pune Maha...
Gorgeous Call Girls In Pune {9xx000xx09} ❤️VVIP ANKITA Call Girl in Pune Maha...Gorgeous Call Girls In Pune {9xx000xx09} ❤️VVIP ANKITA Call Girl in Pune Maha...
Gorgeous Call Girls In Pune {9xx000xx09} ❤️VVIP ANKITA Call Girl in Pune Maha...
 
💸Cash Payment No Advance Call Girls Nagpur 🧿 9332606886 🧿 High Class Call Gir...
💸Cash Payment No Advance Call Girls Nagpur 🧿 9332606886 🧿 High Class Call Gir...💸Cash Payment No Advance Call Girls Nagpur 🧿 9332606886 🧿 High Class Call Gir...
💸Cash Payment No Advance Call Girls Nagpur 🧿 9332606886 🧿 High Class Call Gir...
 
❤️ Call Girls service In Panchkula☎️9815457724☎️ Call Girl service in Panchku...
❤️ Call Girls service In Panchkula☎️9815457724☎️ Call Girl service in Panchku...❤️ Call Girls service In Panchkula☎️9815457724☎️ Call Girl service in Panchku...
❤️ Call Girls service In Panchkula☎️9815457724☎️ Call Girl service in Panchku...
 
Independent Call Girls Service Chandigarh | 8868886958 | Call Girl Service Nu...
Independent Call Girls Service Chandigarh | 8868886958 | Call Girl Service Nu...Independent Call Girls Service Chandigarh | 8868886958 | Call Girl Service Nu...
Independent Call Girls Service Chandigarh | 8868886958 | Call Girl Service Nu...
 
Independent Call Girls Service Chandigarh Sector 17 | 8868886958 | Call Girl ...
Independent Call Girls Service Chandigarh Sector 17 | 8868886958 | Call Girl ...Independent Call Girls Service Chandigarh Sector 17 | 8868886958 | Call Girl ...
Independent Call Girls Service Chandigarh Sector 17 | 8868886958 | Call Girl ...
 
💞 Safe And Secure Call Girls gaya 🧿 9332606886 🧿 High Class Call Girl Service...
💞 Safe And Secure Call Girls gaya 🧿 9332606886 🧿 High Class Call Girl Service...💞 Safe And Secure Call Girls gaya 🧿 9332606886 🧿 High Class Call Girl Service...
💞 Safe And Secure Call Girls gaya 🧿 9332606886 🧿 High Class Call Girl Service...
 
science quiz bee questions.doc FOR ELEMENTARY SCIENCE
science quiz bee questions.doc FOR ELEMENTARY SCIENCEscience quiz bee questions.doc FOR ELEMENTARY SCIENCE
science quiz bee questions.doc FOR ELEMENTARY SCIENCE
 
❤️ Chandigarh Call Girls Service☎️9878799926☎️ Call Girl service in Chandigar...
❤️ Chandigarh Call Girls Service☎️9878799926☎️ Call Girl service in Chandigar...❤️ Chandigarh Call Girls Service☎️9878799926☎️ Call Girl service in Chandigar...
❤️ Chandigarh Call Girls Service☎️9878799926☎️ Call Girl service in Chandigar...
 
Call Girls Service 11 Phase Mohali {7435815124} ❤️ MONA Call Girl in Mohali P...
Call Girls Service 11 Phase Mohali {7435815124} ❤️ MONA Call Girl in Mohali P...Call Girls Service 11 Phase Mohali {7435815124} ❤️ MONA Call Girl in Mohali P...
Call Girls Service 11 Phase Mohali {7435815124} ❤️ MONA Call Girl in Mohali P...
 
Delhi Call Girl Service 📞8650700400📞Just Call Divya📲 Call Girl In Delhi No💰Ad...
Delhi Call Girl Service 📞8650700400📞Just Call Divya📲 Call Girl In Delhi No💰Ad...Delhi Call Girl Service 📞8650700400📞Just Call Divya📲 Call Girl In Delhi No💰Ad...
Delhi Call Girl Service 📞8650700400📞Just Call Divya📲 Call Girl In Delhi No💰Ad...
 
2024 PCP #IMPerative Updates in Rheumatology
2024 PCP #IMPerative Updates in Rheumatology2024 PCP #IMPerative Updates in Rheumatology
2024 PCP #IMPerative Updates in Rheumatology
 
🍑👄Ludhiana Escorts Service☎️98157-77685🍑👄 Call Girl service in Ludhiana☎️Ludh...
🍑👄Ludhiana Escorts Service☎️98157-77685🍑👄 Call Girl service in Ludhiana☎️Ludh...🍑👄Ludhiana Escorts Service☎️98157-77685🍑👄 Call Girl service in Ludhiana☎️Ludh...
🍑👄Ludhiana Escorts Service☎️98157-77685🍑👄 Call Girl service in Ludhiana☎️Ludh...
 
Top 20 Famous Indian Female Pornstars Name List 2024
Top 20 Famous Indian Female Pornstars Name List 2024Top 20 Famous Indian Female Pornstars Name List 2024
Top 20 Famous Indian Female Pornstars Name List 2024
 
Low Rate Call Girls Jaipur {9521753030} ❤️VVIP NISHA CCall Girls in Jaipur Es...
Low Rate Call Girls Jaipur {9521753030} ❤️VVIP NISHA CCall Girls in Jaipur Es...Low Rate Call Girls Jaipur {9521753030} ❤️VVIP NISHA CCall Girls in Jaipur Es...
Low Rate Call Girls Jaipur {9521753030} ❤️VVIP NISHA CCall Girls in Jaipur Es...
 
Erotic Call Girls Bangalore {7304373326} ❤️VVIP SIYA Call Girls in Bangalore ...
Erotic Call Girls Bangalore {7304373326} ❤️VVIP SIYA Call Girls in Bangalore ...Erotic Call Girls Bangalore {7304373326} ❤️VVIP SIYA Call Girls in Bangalore ...
Erotic Call Girls Bangalore {7304373326} ❤️VVIP SIYA Call Girls in Bangalore ...
 
💞 Safe And Secure Call Girls Mysore 🧿 9332606886 🧿 High Class Call Girl Servi...
💞 Safe And Secure Call Girls Mysore 🧿 9332606886 🧿 High Class Call Girl Servi...💞 Safe And Secure Call Girls Mysore 🧿 9332606886 🧿 High Class Call Girl Servi...
💞 Safe And Secure Call Girls Mysore 🧿 9332606886 🧿 High Class Call Girl Servi...
 
The Events of Cardiac Cycle - Wigger's Diagram
The Events of Cardiac Cycle - Wigger's DiagramThe Events of Cardiac Cycle - Wigger's Diagram
The Events of Cardiac Cycle - Wigger's Diagram
 
💸Cash Payment No Advance Call Girls Hyderabad 🧿 9332606886 🧿 High Class Call ...
💸Cash Payment No Advance Call Girls Hyderabad 🧿 9332606886 🧿 High Class Call ...💸Cash Payment No Advance Call Girls Hyderabad 🧿 9332606886 🧿 High Class Call ...
💸Cash Payment No Advance Call Girls Hyderabad 🧿 9332606886 🧿 High Class Call ...
 
Call Girl Service In Mumbai ❤️🍑 9xx000xx09 👄🫦Independent Escort Service Mumba...
Call Girl Service In Mumbai ❤️🍑 9xx000xx09 👄🫦Independent Escort Service Mumba...Call Girl Service In Mumbai ❤️🍑 9xx000xx09 👄🫦Independent Escort Service Mumba...
Call Girl Service In Mumbai ❤️🍑 9xx000xx09 👄🫦Independent Escort Service Mumba...
 
💸Cash Payment No Advance Call Girls Bhopal 🧿 9332606886 🧿 High Class Call Gir...
💸Cash Payment No Advance Call Girls Bhopal 🧿 9332606886 🧿 High Class Call Gir...💸Cash Payment No Advance Call Girls Bhopal 🧿 9332606886 🧿 High Class Call Gir...
💸Cash Payment No Advance Call Girls Bhopal 🧿 9332606886 🧿 High Class Call Gir...
 

High Intensity Prescribers in the ED

  • 1. The new engl and jour nal of medicine n engl j med 376;7 nejm.org  February 16, 2017 663 From the Department of Health Policy and Management, Harvard T.H. Chan School of Public Health (M.L.B.), the De- partment of Health Care Policy, Harvard Medical School (A.R.O., A.B.J.), the Divi- sion of General Internal Medicine and Primary Care, Department of Medicine, Brigham and Women’s Hospital (M.L.B.), and the Department of Medicine, Massa- chusetts General Hospital (A.B.J.), Boston, and the National Bureau of Economic Re- search, Cambridge (A.B.J.) — all in Massa- chusetts. Address reprint requests to Dr. Barnett at the Department of Health Pol- icy and Management, Harvard T.H. Chan School of Public Health, Kresge Bldg., 4th Fl., 677 Huntington Ave., Boston, MA 02115, or at ­mbarnett@​­hsph​.­harvard​.­edu. This article was updated on February 16, 2017, at NEJM.org. N Engl J Med 2017;376:663-73. DOI: 10.1056/NEJMsa1610524 Copyright © 2017 Massachusetts Medical Society. BACKGROUND Increasing overuse of opioids in the United States may be driven in part by physician prescribing. However, the extent to which individual physicians vary in opioid pre- scribing and the implications of that variation for long-term opioid use and adverse outcomes in patients are unknown. METHODS We performed a retrospective analysis involving Medicare beneficiaries who had an index emergency department visit in the period from 2008 through 2011 and had not received prescriptions for opioids within 6 months before that visit. After identifying the emergency physicians within a hospital who cared for the patients, we categorized the physicians as being high-intensity or low-intensity opioid prescrib- ers according to relative quartiles of prescribing rates within the same hospital. We compared rates of long-term opioid use, defined as 6 months of days supplied, in the 12 months after a visit to the emergency department among patients treated by high-intensity or low-intensity prescribers, with adjustment for patient charac- teristics. RESULTS Our sample consisted of 215,678 patients who received treatment from low-inten- sity prescribers and 161,951 patients who received treatment from high-intensity prescribers. Patient characteristics, including diagnoses in the emergency depart- ment, were similar in the two treatment groups. Within individual hospitals, rates of opioid prescribing varied widely between low-intensity and high-intensity pre- scribers (7.3% vs. 24.1%). Long-term opioid use was significantly higher among patients treated by high-intensity prescribers than among patients treated by low- intensity prescribers (adjusted odds ratio, 1.30; 95% confidence interval, 1.23 to 1.37; P<0.001); these findings were consistent across multiple sensitivity analyses. CONCLUSIONS Wide variation in rates of opioid prescribing existed among physicians practicing within the same emergency department, and rates of long-term opioid use were in- creased among patients who had not previously received opioids and received treatment from high-intensity opioid prescribers. (Funded by the National Insti- tutes of Health.) ABSTR ACT Opioid-Prescribing Patterns of Emergency Physicians and Risk of Long-Term Use Michael L. Barnett, M.D., Andrew R. Olenski, B.S., and Anupam B. Jena, M.D., Ph.D.​​ Special Article The New England Journal of Medicine Downloaded from nejm.org on February 15, 2017. For personal use only. No other uses without permission. Copyright © 2017 Massachusetts Medical Society. All rights reserved.
  • 2. n engl j med 376;7 nejm.org  February 16, 2017664 The new engl and jour nal of medicine R  ates of opioid prescribing and opioid-related overdose deaths have qua- drupled in the United States over the past three decades.1-3 This epidemic has increasingly affected the elderly Medicare population, among whom rates of hospitalization for opioid overdoses quintupled from 1993 through 2012.4-6 The risks of opioid use are particularly pronounced among the elderly, who are vulnerable to their sedating side effects, even at therapeutic doses.7 Multiple studies have shown increased rates of falls, frac- tures, and death from any cause associated with opioid use in this population.8-11 Even short-term opioid use may confer a predisposition to these side effects and to opioid dependence.12 It is frequently argued that the prescribing be- havior of physicians has been a driver of the opioid epidemic.13,14 Prescribing has increased to the point that in 2010, enough opioids were prescribed in the United States to provide every American adult with 5 mg of hydrocodone every 4 hours for a month.1,14 This growth may be driven in part by high variability in physician prescribing of opi- oids; this variability may reflect overprescribing beyond what is required for appropriate pain management.1,15,16 This inconsistency is not sur- prising, because few clinical guidelines exist, and there is limited evidence to direct the appropri- ate use of opioids.17,18 However, few studies have investigated the extent to which individual phy- sicians vary in opioid prescribing and the impli- cations of that variation for long-term opioid use and related adverse outcomes in patients. To examine the extent to which emergency phy- sicians within the same hospital varied in rates of opioid prescribing, we studied a national sample of Medicare beneficiaries who received treatment in an emergency department and who had not used prescription opioids within 6 months before the index visit to the emergency department. In order to understand how initial exposure to an opioid relates to subsequent outcomes, we identified high- intensity and low-intensity opioid prescribers with- in each hospital and examined rates of long-term opioid use and future hospitalizations among pa- tients treated by these two groups of prescrib- ers.19,20 To address the challenge of selection bias, we relied on the fact that patients are unlikely to choose an emergency department physician once they have chosen a facility. Methods Study Population Using the Centers for Medicare and Medicaid Ser- vices carrier files for a 20% random sample of beneficiaries from January 1, 2008, through De- cember 31, 2011, we identified index emergency department visits at acute care hospitals by Medi- care beneficiaries. We defined an index visit as the earliest visit at which a beneficiary had an evalu- ation and a management claim by an emergency medicine physician with a place-of-service desig- nation in the emergency department. Emergency medicine physicians were defined as physicians with an emergency medicine specialty who billed 90% or more of claims with an emergency department place of service. We included only one index visit to the emergency department per beneficiary and excluded all visits to the emer- gency department that resulted in a hospital ad- mission. We limited our analyses to beneficiaries who had been continuously enrolled in Medicare Part D for 18 months or more, including at least the period from 6 months before the index visit to 12 months afterward. We included only beneficia- ries who had not had an opioid prescription filled in the 6 months before the index visit. In addition, we excluded beneficiaries with hospice claims or a cancer diagnosis between 2008 and 2012. We assigned each index emergency department visit to a physician according to the billing Na- tional Provider Identifier (NPI) and then linked each visit to a hospital by matching to facility claims in the outpatient department file according to the date and beneficiary. To ensure that we had an adequate sample size at the physician and hos- pital level, we excluded physicians with fewer than five emergency department visits and hospitals with fewer than five physicians billing for emer- gency department visits in our sample. If physi- cians practiced in more than one hospital, they were assigned to the hospital at which they had the most visits, and any visits at other facilities were excluded. This study was approved by the institutional review board at Harvard Medical School, which waived the requirement for informed consent since the data were deidentified and only aggre- gate results would be reported. The New England Journal of Medicine Downloaded from nejm.org on February 15, 2017. For personal use only. No other uses without permission. Copyright © 2017 Massachusetts Medical Society. All rights reserved.
  • 3. n engl j med 376;7 nejm.org  February 16, 2017 665 Opioid Prescribing and Risk of Long-Term Use Definitions of Opioid Prescriptions and Intensity of Physicians’ Prescribing We identified prescription claims corresponding to an opioid (excluding methadone) according to the National Drug Code in the Medicare Part D database.16 We attributed an opioid prescription to an index emergency department visit and the as- sociated physician if it was filled by the patient within 7 days after the date of the emergency de- partment visit; in a sensitivity analysis, we restrict- ed this duration to 3 days. This attribution method was necessary because prescriber NPI informa- tion is not available in the Part D database (see the Methods and Results section in the Supple- mentary Appendix, available with the full text of this article at NEJM.org). For this and subsequent opioid prescriptions, we extracted the number of days for which opiates were supplied and calcu- lated the morphine equivalents dispensed, using standard conversion tables.21 We defined the main exposure as treatment by a “high-intensity” or “low-intensity” opioid pre- scribing physician within the same hospital. For each physician, we first calculated the proportion of all emergency department visits after which an opioid prescription was filled. We then grouped physicians into quartiles of rates of opioid pre- scribing within each hospital and classified physi- cians as being in the top (high-intensity) or bot- tom (low-intensity) quartile of prescribing rates. In 93 hospitals, because of a high number of pre- scribers who did not prescribe opioids, there were fewer than four separate groups of prescribers to assign to quartiles; therefore, the highest and low- est prescribers in a hospital were assigned to the high-intensity and low-intensity groups. We also defined an alternative exposure, classifying phy- sicians according to the median dose (in morphine equivalents) of prescriptions filled after an emer- gency department visit (“high-dose intensity” and “low-dose intensity”). Outcomes Our primary outcome was long-term opioid use, which we defined as 180 days or more of opioids supplied in the 12 months after an index emer- gency department visit, excluding prescriptions within 30 days after the index visit. We applied this exclusion because otherwise this outcome, by de- sign, would be correlated with our definition of the main exposure. We chose 180 days as a spe- cific marker for clinically significant long-term opioid use beyond the common duration of 90 days described in previous literature.16,22,23 Therefore, this outcome captures the extent to which other physicians prescribe opioids for the subsequent 12 months after a patient’s index emergency de- partment visit. Secondary outcomes were rates of hospital encounters (emergency department visits, hospi- talizations, or both), including those potentially related to adverse effects of opioids and those associated with a selection of medical conditions that were unlikely to be influenced by opioid use, in the 12 months after an index emergency depart- ment visit (definitions are provided in the Methods and Results section in the Supplementary Appen- dix).8-10,24 To assess for possible undertreatment of pain by low-intensity prescribers that could have led to repeat emergency care, we also measured rates of repeat emergency department visits at 14 and 30 days that resulted in the same primary di- agnosis as the initial emergency department visit, classified according to Clinical Classifications Soft- ware (CCS) groups (categorizations of codes in the International Classification of Diseases, 9th Revision).25 Patient Covariates We collected information on the patients’ age, sex, race or ethnic group, dual eligibility for Medicaid and Medicare coverage, and disability status.26 Us- ing the Chronic Conditions Warehouse database, we also captured the presence of any of 11 chronic conditions (Table 1) as well as the number of coex- isting chronic conditions that a patient had at the time of an index emergency department visit. Statistical Analysis Our strategy to reduce selection bias relied on the assumption that within the same hospital, patients do not choose specific emergency physicians, and therefore patients treated by physicians of varying opioid prescribing intensity may be similar with respect to both observable and unobservable char- acteristics. To assess this approach, we compared the characteristics of patients who saw high-inten- sity prescribers with those who saw low-intensity prescribers. We assessed balance in the case mix by comparing rates of visits classified according to the top 25 CCS groups, as well as by plotting the The New England Journal of Medicine Downloaded from nejm.org on February 15, 2017. For personal use only. No other uses without permission. Copyright © 2017 Massachusetts Medical Society. All rights reserved.
  • 4. n engl j med 376;7 nejm.org  February 16, 2017666 The new engl and jour nal of medicine cumulative distribution of the primary-diagnosis CCS group between high-intensity and low-inten- sity prescribers. Differences in distributions be- tween groups were assessed with the use of the Kolmogorov–Smirnov test.27 We then computed unadjusted rates and odds ratios for each outcome, stratified according to treatment by a high-intensity or low-intensity opioid prescriber. To account for residual differ- ences between patient populations, we estimated adjusted odds ratios with patient-level multivari- able logistic regression. Dependent variables were the occurrence of primary or secondary outcomes. The key explanatory variable was a binary indica- tor for whether a patient was treated by a high- intensity or low-intensity prescriber (the middle two quartiles of prescribers were not included in these models). Other covariates included the patients’ age, sex, race or ethnic group, Medicaid eligibility, and disability status, as well as the presence of 11 different chronic conditions. We prespecified several subgroup analyses to assess for heterogeneity (Table 2). All models account- ed for grouping of patients within hospitals with Characteristic Patients Treated by Low-Intensity Prescriber (N = 215,678)† Patients Treated by High-Intensity Prescriber (N = 161,951)† P Value‡ Age (yr) 68.8±16.3 68.2±16.4 <0.001 Female sex (%) 64.5 64.5 0.75 White race (%)§ 76.6 75.9 0.03 Medicare–Medicaid dual eligibility (%) 49.3 49.6 0.19 Disabled (%) 36.4 37.6 <0.001 Chronic conditions (no.) 3.6±2.3 3.5±2.3 <0.001 Presence of chronic illness (%) Acute myocardial infarction 49.8 48.5 <0.001 Alzheimer’s dementia 17.5 16.0 <0.001 Atrial fibrillation 13.6 12.7 <0.001 Cerebrovascular disease 17.3 16.3 <0.001 Chronic kidney disease 20.6 20.1 <0.001 Chronic obstructive pulmonary disease 28.1 27.2 <0.001 Congestive heart failure 30.5 29.0 <0.001 Depression 39.5 39.5 0.94 Diabetes 37.8 37.7 0.69 Hyperlipidemia 69.5 69.1 0.09 Hypertension 78.1 77.4 <0.001 Census region (%) Northeast 19.8 20.9 0.03 Midwest 24.4 23.2 0.01 South 38.4 38.6 0.82 West 17.3 17.3 0.97 * Plus–minus values are means ±SD. † Within each hospital, high-intensity and low-intensity prescribers were defined as the top (high) or bottom (low) quar- tile of emergency physician prescribers in terms of opioid prescribing. Since many physicians did not prescribe opioids, some hospitals had many physicians with prescribing rates equal to zero in the low-intensity prescriber group, making it larger overall than the high-intensity group. Low-intensity prescribers included 8297 physicians; the total number (±SD) of patients per physician was 26.0±18.6. High-intensity prescribers included 6133 physicians; the total number of pa- tients per physician was 26.4±18.5. ‡ Unadjusted P values were estimated with the use of Student’s t-test for means or the z-test for comparison of proportions. § Race or ethnic group was self-reported. Table 1. Characteristics of the Patients, According to Opioid Prescribing Intensity of Physician Seen.* The New England Journal of Medicine Downloaded from nejm.org on February 15, 2017. For personal use only. No other uses without permission. Copyright © 2017 Massachusetts Medical Society. All rights reserved.
  • 5. n engl j med 376;7 nejm.org  February 16, 2017 667 Opioid Prescribing and Risk of Long-Term Use the use of robust standard errors clustered at the hospital level.28 The hypothetical long-term effect of filling an initial opioid prescription after an emergency department visit versus not filling a prescription was estimated to approximate the number of pa- tients who would need to be prescribed an initial opioid for one patient to become a long-term user. A definition of “number needed to harm” is pro- vided in the Methods section in the Supplemen- tary Appendix.29 We performed additional sensitivity analyses to address the possibility of selection bias and sensitivity to design assumptions (details are pro- vided in the Methods section in the Supplementary Appendix). These analyses included an alternative exposure in which intensity was defined accord- ing to the median dose of opioid prescription filled after an emergency department visit, as described above. Replicating our results with an alternative definition of exposure that operates through a similar causal pathway (increased opioid exposure) could argue against selection bias, particularly if the two exposures (dose and frequency of opioid prescribing) are minimally correlated. All analyses were performed with the use of Stata software, version 14.1 (StataCorp). The 95% confidence intervals around reported estimates reflect 0.025 in each tail, or P values no higher than 0.05. Results Our sample consisted of 215,678 patients treated by a low-intensity opioid prescriber and 161,951 patients treated by a high-intensity opioid pre- scriber during an index emergency department visit. Overall, the characteristics of patients treated by high-intensity opioid prescribers were similar to those of patients treated by low-intensity pre- scribers, although several differences were signifi- cant given the large sample size (Table 1). Diag- noses in patients seen by high-intensity prescribers and those seen by low-intensity prescribers were similar (P = 0.87 by the Kolmogorov–Smirnov test for differences in the distribution of 300 CCS groups, according to prescriber group [Fig. S1 in the Supplementary Appendix; for distribution of the top 25 of 300 CCS diagnosis groups, according to prescriber group, see Fig. S2 in the Supplemen- tary Appendix]). On average, rates of opioid prescribing between low-intensity prescribers and high-intensity pre- scribers varied by a factor of 3.3 within the same hospital (7.3% vs. 24.1% of emergency department visits, P0.001) (Table 2 and Fig. 1A). Across all subgroups, prescribing rates among high-intensi- ty prescribers were triple those among low-inten- sity prescribers. The highest average rate was seen among patients who visited the emergency de- partment with an injury (23.7%) (Table 2). There was minimal correlation between physicians’ pre- scribing rates and the median initial dose of an opioid prescription that was filled (r = −0.08) (Fig. S3 and Table S1 in the Supplementary Appendix) or type of opioid prescribed (Table S2 in the Sup- plementary Appendix). Overall, long-term opioid use at 12 months was significantly higher among patients treated by high-intensity prescribers than among patients treated by low-intensity prescribers (1.51% vs. 1.16%; unadjusted odds ratio, 1.31; 95% confi- dence interval [CI], 1.24 to 1.39) (Table 2 and Fig. 2). After adjustment, there was minimal change in this difference (adjusted odds ratio, 1.30; 95% CI, 1.23 to 1.37). This finding corre- sponds to a number needed to harm of 48 pa- tients receiving an opioid prescription to theo- retically lead to 1 excess long-term opioid user. We observed a stepwise increase in long-term opioid use with exposure to physicians in each quartile of opioid prescribing frequency. As com- pared with the first (low-intensity) quartile, pa- tients treated by physicians in the second quar- tile had an adjusted odds ratio for long-term opioid use of 1.10 (95% CI, 1.04 to 1.16) and patients treated by physicians in the third quartile had an adjusted odds ratio of 1.19 (95% CI, 1.12 to 1.25) (Fig. 1B, and Table S3 in the Supplementary Ap- pendix). Differences in long-term opioid use be- tween patients treated by high-intensity prescribers and those treated by low-intensity opioid prescrib- ers were consistent across subgroups, with mini- mal change after multivariable adjustment (Fig. 2). Rates of opioid-related hospital encounters and encounters for fall or fracture were significantly higher in the 12 months after an index emergency department visit among patients treated by high- intensity opioid prescribers than among patients treated by low-intensity opioid prescribers (rates of any opioid-related encounter, 9.96% vs. 9.73%; adjusted odds ratio, 1.03; 95% CI, 1.00 to 1.05; P = 0.02; rates of encounters for fall or fracture, 4.56% vs. 4.28%; adjusted odds ratio, 1.07; 95% CI, The New England Journal of Medicine Downloaded from nejm.org on February 15, 2017. For personal use only. No other uses without permission. Copyright © 2017 Massachusetts Medical Society. All rights reserved.
  • 6. n engl j med 376;7 nejm.org  February 16, 2017668 The new engl and jour nal of medicine Variable Initial Rate of Opioid Prescription in Emergency Department Rate of Long-Term Use Average Rate Low-Intensity Prescriber High-Intensity Prescriber Low-Intensity Prescriber High-Intensity Prescriber percent Overall rate of opioid prescribing 14.7 7.3 24.1 1.16 1.51 Rate of prescribing according to patient characteristic Age 65 yr 17.9 8.8 28.9 2.09 2.82 65–74 yr 16.4 8.4 26.4 0.86 1.00 75–84 yr 12.3 6.0 20.4 0.68 0.89 ≥85 yr 8.9 4.3 15.6 0.86 1.01 Sex Male 15.1 7.6 24.7 1.22 1.53 Female 14.4 7.1 23.8 1.13 1.51 Race White 14.6 7.5 23.7 1.16 1.50 Black 14.9 6.8 25.0 1.38 1.87 Medicare–Medicaid dual eligibility No 14.4 7.4 23.4 0.71 0.87 Yes 15.0 7.2 24.8 1.62 2.17 No. of chronic conditions† 0 18.7 9.5 29.9 1.29 1.73 1 or 2 16.9 8.5 27.4 1.07 1.52 ≥3 13.3 6.5 22.0 1.17 1.48 Alzheimer’s disease No 15.9 8.0 25.9 1.15 1.52 Yes 8.5 4.0 14.7 1.19 1.49 Disabled No 13.4 6.7 22.1 0.71 0.87 Yes 17.0 8.3 27.5 1.95 2.59 Depression No 14.8 7.4 24.2 0.78 1.01 Yes 14.5 7.1 23.9 1.74 2.28 Census region Northeast 11.9 5.2 20.5 0.78 1.11 Midwest 14.0 6.9 23.4 1.27 1.45 South 15.9 8.4 25.3 1.33 1.81 West 16.2 7.7 26.7 1.07 1.44 Emergency department visit for injury‡ No 13.7 6.7 22.7 1.16 1.53 Yes 23.7 12.6 35.8 1.14 1.42 * Long-term opioid use was defined as 6 months of days of opioids supplied in the 12 months after an index emergency department visit, ­excluding the first 30 days after the index emergency department visit. † The number of chronic conditions among 11 possible conditions is shown. These conditions are the following: acute myocardial infarction, Alzheimer’s dementia, atrial fibrillation, cerebrovascular disease, chronic kidney disease, chronic obstructive pulmonary disease, congestive heart failure, depression, diabetes, hyperlipidemia, and hypertension. ‡ An emergency department visit for an injury was defined as any emergency department visit with an “E” code associated with an injury ­(according to the codes in the International Classification of Diseases, 9th Revision). Of patients who visited an emergency department for a reason other than an injury, 195,651 saw low-intensity prescribers and 144,895 saw high-intensity prescribers. Of patients who visited an emergency department because of an injury, 20,027 saw low-intensity prescribers and 17,056 saw high-intensity prescribers. Table 2. Rate of Filling a Prescription for Opioids within 7 Days after Emergency Department Visit and Rate of Long-Term Use, According to Opioid Prescribing Intensity of Physician Seen.* The New England Journal of Medicine Downloaded from nejm.org on February 15, 2017. For personal use only. No other uses without permission. Copyright © 2017 Massachusetts Medical Society. All rights reserved.
  • 7. n engl j med 376;7 nejm.org  February 16, 2017 669 Opioid Prescribing and Risk of Long-Term Use 1.03 to 1.11; P0.001) (Table 3). There was no significant difference in 12-month rates of over- all hospital encounters or non–opioid-related en- counters. Assessment of rates of short-term emer- gency department revisits for possible evidence of undertreated pain showed that rates of 14-day and 30-day repeat emergency department visits with the same primary diagnosis as the index visit were similar in the two prescriber groups (P0.07) (Table S4 in the Supplementary Appendix). We replicated the main analysis described above in multiple other sensitivity analyses, including one that used a propensity score–matched cohort (see the Results section in the Supplementary Appen- dix), although the finding of increased hospital encounters for falls or fractures with the use of propensity score matching (P = 0.05) and with the use of CCS category fixed effects (P = 0.12) was not significant (Table S6 in the Supplementary Appendix). In analyses in which physicians were categorized as being high or low “dose intensity” prescribers, we found increased odds of long-term opioid use among patients treated by high dose- intensity prescribers (odds ratio, 1.32; 95% CI, 1.19 to 1.46) (Table S6 and Fig. S4 in the Supple- mentary Appendix). Discussion In a large, national sample of patients enrolled in Medicare Part D who received care in an emer- gency department and who had not used prescrip- tion opioids in the 6 months before the visit to the emergency department, we found substantial variation in the opioid prescribing patterns of emergency physicians within the same hospital. The intensity of a physician’s opioid prescribing was positively associated with the probability that a patient would become a long-term opioid user over the subsequent 12 months. Although our study was observational, we sought to minimize selection bias by comparing the characteristics of patients seen by different emergency physicians within the same hospital. The association between physician prescribing rates and increased long- term opioid use was consistent across numerous subgroups and across all quartiles of physician prescribing in a dose–response pattern. It is commonly thought that opioid dependence often begins through an initial, possibly chance, exposure to a physician-prescribed opioid, al- though data from studies to empirically evaluate this claim are lacking. Our results provide evi- dence that this mechanism could drive initiation of long-term opioid use through either increased rates of opioid prescription or prescription of a high, versus a low, dose of opioid. Although cau- sality cannot be established from this observa- Figure 1. Prescribing Rates and Adjusted Odds Ratios for Long-Term Opioid Use, According to Quartile of Physician Opioid Prescribing. Panel A shows rates of opioid prescribing by emergen- cy physicians according to within-hospital quartile. I bars represent 95% confidence intervals. Panel B shows the adjusted odds ratios and corresponding 95% confidence intervals for rates of long-term opioid use, according to quartile of physician opioid prescrib- ing. Physicians in each quartile were compared with those in the lowest prescribing quartile. Odds ratios were estimated with the use of logistic-regression models. PercentofEmergencyDepartment VisitswithanOpioidPrescription 30 20 25 15 10 5 0 1 2 3 4 Prescriber Quartile B A OddsRatioforLong-TermOpioidUse 1.4 1.2 1.3 1.1 1.0 1 (Low intensity, reference) 2 3 4 (High intensity) Prescriber Quartile The New England Journal of Medicine Downloaded from nejm.org on February 15, 2017. For personal use only. No other uses without permission. Copyright © 2017 Massachusetts Medical Society. All rights reserved.
  • 8. n engl j med 376;7 nejm.org  February 16, 2017670 The new engl and jour nal of medicine tional study, if our results represent a causal re- lationship, for every 48 patients prescribed a new opioid in the emergency department who might not otherwise use opioids, 1 will become a long- term user; this is a low number needed to harm for such a common therapy. Of course, prescriptions provided by other phy- sicians in the months after an emergency depart- ment visit are necessary for long-term opioid use to take hold. Conversion to long-term use may be driven partly by clinical “inertia” leading outpa- tient clinicians to continue providing previous prescriptions. Such clinical inertia may affect only a narrow segment of the population; this could explain why rates of initial opioid prescribing may vary by a factor of three, whereas long-term use varies by only approximately 30%. It is impor- tant to acknowledge that patients treated by high- Figure 2. Unadjusted and Adjusted Odds Ratios for Long-Term Opioid Use, According to Treatment by High-Intensity or Low-Intensity Opioid Prescriber. All unadjusted odds ratios were estimated with the use of bivariate logistic regression with the occurrence of long- term opioid use as the dependent variable and exposure to a high-intensity provider as the key explanatory variable. All adjusted models had further adjustment for the patients’ age, sex, race or ethnic group, Medicare–Medicaid dual eligibility, and disability status and the presence of 11 chronic conditions. 1.2 1.6 2.0 Overall opioid use at 12 mo Age 65 yr 65–74 yr 75–84 yr ≥85 yr Sex Male Female Race White Black Census region Northeast Midwest South West No. of chronic conditions None 1 or 2 ≥3 Medicare–Medicaid dual eligibility No Yes Depression No Yes Emergency department visit for injury No Yes Alzheimer’s disease No Yes Disabled No Yes 1.31 1.36 1.16 1.32 1.18 1.26 1.34 1.29 1.36 1.43 1.14 1.37 1.35 1.35 1.43 1.26 1.22 1.35 1.30 1.32 1.32 1.25 1.32 1.26 1.23 1.33 Unadjusted Odds Ratio (95% CI) Odds Ratio Adjusted (95% CI) Subgroup 1.26 (1.09–1.44) 1.34 (1.25–1.44) 1.25 (1.05–1.49) 1.31 (1.23–1.39) 1.30 (1.23–1.38) 1.30 (1.21–1.40) 1.20 (1.08–1.33) 1.34 (1.26–1.44) 1.29 (1.18–1.41) 1.24 (1.13–1.36) 1.41 (1.26–1.58) 1.36 (1.15–1.61) 1.25 (1.17–1.34) 1.34 (1.17–1.53) 1.12 (1.00–1.27) 1.42 (1.23–1.64) 1.35 (1.19–1.53) 1.36 (1.25–1.48) 1.28 (1.20–1.37) 1.25 (1.14–1.37) 1.33 (1.24–1.43) 1.18 (0.98–1.42) 1.33 (1.15–1.54) 1.17 (1.03–1.32) 1.30 (1.23–1.37) 0.8 1.37 (1.27–1.48) The New England Journal of Medicine Downloaded from nejm.org on February 15, 2017. For personal use only. No other uses without permission. Copyright © 2017 Massachusetts Medical Society. All rights reserved.
  • 9. n engl j med 376;7 nejm.org  February 16, 2017 671 Opioid Prescribing and Risk of Long-Term Use intensity opioid prescribers may have dispropor- tionately required appropriate opioid therapy, although some of the variation we observed in rates of opioid prescribing may also indicate over- use. If differences in appropriate use were a major driver of variation in prescribing, we may have expected increased rates of short-term emergency department revisits due to inadequately treated pain among the low-intensity prescriber groups. However, we did not find a difference in such rates between prescriber groups; this suggests that in- creased opioid prescribing did not prevent revis- its to the emergency department. Our results are unlikely to be explained by se- lection bias for several reasons. First, our analysis focused on variation in opioid prescribing of emer- gency physicians within the same hospital; these physicians are unlikely to select or attract system- atically different patient populations. Second, even though there were small differences in character- istics between patients treated by the two pre- scriber groups, adjustment for these characteris- tics did not change our results with respect to long-term opioid use. We also replicated our re- sults in a range of sensitivity analyses, and the case mix of emergency department visits across 300 diagnosis categories was statistically indistinguish- able between groups. In addition, we replicated our results with an alternative exposure definition based on opioid dose; this exposure was mini- mally correlated with the frequency of opioid pre- scribing by physicians. Our study has several limitations. Most impor- tant, this is an observational study and cannot be interpreted as causal, although our findings were robust in several sensitivity analyses addressing selection bias. Second, since we could not ob- serve whether an opioid prescription was appro- Type of Hospital Encounter 12-Mo Encounter Rate Adjusted Odds Ratio (95% CI)† P Value† Patients Treated by Low-Intensity Prescriber (N = 215,678) Patients Treated by High-Intensity Prescriber (N = 161,951) % of patients Any hospital encounter 60.5 60.3 0.99 (0.97–1.00) 0.13 Any hospitalization 46.1 45.8 0.99 (0.97–1.00) 0.15 Any emergency department visit 57.4 57.1 0.99 (0.97–1.00) 0.07 Any opioid-related hospital encounter 9.73 9.96 1.03 (1.00–1.05) 0.02 Fall or fracture 4.28 4.56 1.07 (1.03–1.11) 0.001 Constipation 4.16 4.11 0.99 (0.96–1.02) 0.44 Respiratory failure 2.04 2.01 0.98 (0.94–1.03) 0.46 Opioid poisoning 0.07 0.10 1.40 (1.12–1.74) 0.001 Any selected non–opioid-related hospital encounter 11.77 11.75 1.00 (0.98–1.02) 0.85 Hyperglycemia 0.24 0.24 0.99 (0.87–1.14) 0.93 Urinary tract infection 1.08 1.13 1.04 (0.98–1.11) 0.17 Atrial fibrillation 6.48 6.39 0.98 (0.95–1.01) 0.24 Stroke 4.12 4.08 0.99 (0.96–1.02) 0.52 * A hospital encounter refers to a hospitalization or an emergency department visit. Definitions are provided in the Methods section in the Supplementary Appendix. CI denotes confidence interval. † Adjusted odds ratios and P values were estimated with the use of logistic-regression models with occurrence of an opi- oid-related hospitalization in the 12 months after an emergency department visit as the dependent variable. The key co- variate was an indicator for being seen by a high-intensity or a low-intensity prescriber. All models were adjusted for age, sex, race and ethnic group, Medicare–Medicaid dual eligibility, and the presence of 11 chronic conditions. Table 3. Hospital Encounters within 12 Months after an Index Emergency Department Visit to a Low-Intensity or High- Intensity Opioid Prescriber.* The New England Journal of Medicine Downloaded from nejm.org on February 15, 2017. For personal use only. No other uses without permission. Copyright © 2017 Massachusetts Medical Society. All rights reserved.
  • 10. n engl j med 376;7 nejm.org  February 16, 2017672 The new engl and jour nal of medicine priate, our ability to quantify the extent of over- use of opioids was limited. Third, because we focused on Medicare patients with Part D enroll- ment and emergency department visits, our re- sults may not be generalizable to other popula- tions. However, the growing prevalence of opioid misuse among the elderly makes this an impor- tant group to study.16,24 Fourth, the association between high-intensity opioid prescribers and opi- oid-related hospital encounters within 12 months after the index emergency department visit was small and not significant in some sensitivity analy- ses. In addition, for outcomes with a significant association, the absolute difference in rates of hospital encounters between groups was small (e.g., an absolute difference of 0.23 percentage points for any opioid-related encounter) (Table 3). Therefore, we have weaker evidence to support this association than our results on long-term opi- oid use, and if it were causal, the clinical magni- tude of this association would be small. Fifth, we were unable to unequivocally attribute an opioid prescription to an emergency physician; however, our analyses were robust with respect to a stricter threshold of 3 days to fill a prescrip- tion for opioids from an emergency physician.16 Finally, our statistical tests do not account for the false positive rate associated with multiple second- ary analyses; therefore, P values should be regard- ed as exploratory. In conclusion, we found variation by a factor of more than three in rates of opioid prescribing by emergency physicians within the same hospital and increased rates of long-term opioid use among patients treated by high-intensity opioid prescrib- ers. These results suggest that an increased likeli- hood of receiving an opioid for even one encounter could drive clinically significant future long-term opioid use and potentially increased adverse out- comes among the elderly. Future research may explore whether this variation reflects overpre- scription by some prescribers and whether it is amenable to intervention. Supported by a grant from the Office of the Director, Na- tional Institutes of Health (NIH) (NIH Director’s Early Indepen- dence Award, 1DP5OD017897-01, to Dr. Jena). Dr. Barnett reports serving as medical advisor to and holding stock in Ginger.io; and Dr. Jena, receiving consulting fees from Pfizer, Hill-Rom Services, Bristol-Myers Squibb, Novartis Phar- maceuticals, Vertex Pharmaceuticals, and Precision Health Eco- nomics. No other potential conflict of interest relevant to this article was reported. Disclosure forms provided by the authors are available with the full text of this article at NEJM.org. References 1. Vital signs:​overdoses of prescription opioid pain relievers — United States, 1999–2008. MMWR Morb Mortal Wkly Rep 2011;​60:​1487-2. 2. Prescription opioid overdose data. At- lanta:​Centers for Disease Control and Prevention, 2016 (http://www​.cdc​.gov/​ drugoverdose/​data/​overdose​.html). 3. National Institute on Drug Abuse. America’s addiction to opioids:​heroin and prescription drug abuse. May 14, 2014 (https:/​/​www​.drugabuse​.gov/​about-nida/​ legislative-activities/​testimony-to -congress/​2016/​americas-addiction-to -opioids-heroin-prescription-drug-abuse). 4. Healthcare Cost and Utilization Proj- ect. Hospital inpatient utilization related to opioid overuse among adults, 1993- 2012. August 2014 (https:/​/​www​.hcup-us​ .ahrq​.gov/​reports/​statbriefs/​sb177 -Hospitalizations-for-Opioid-Overuse​.jsp). 5. Vestal C. Older addicts squeezed by opioid epidemic. Stateline. July 26, 2016 (http://pew​.org/​2asv3TO). 6. Dufour R, Joshi AV, Pasquale MK, et al. The prevalence of diagnosed opioid abuse in commercial and Medicare man- aged care populations. Pain Pract 2014;​ 14(3):​E106-E115. 7. Makris UE, Abrams RC, Gurland B, Reid MC. Management of persistent pain in the older patient: a clinical review. JAMA 2014;​312:​825-36. 8. Miller M, Stürmer T, Azrael D, Levin R, Solomon DH. Opioid analgesics and the risk of fractures in older adults with arthritis. J Am Geriatr Soc 2011;​59:​430-8. 9. Solomon DH, Rassen JA, Glynn RJ, Lee J, Levin R, Schneeweiss S. The com- parative safety of analgesics in older adults with arthritis. Arch Intern Med 2010;​170:​1968-76. 10. Buckeridge D, Huang A, Hanley J, et al. Risk of injury associated with opioid use in older adults. J Am Geriatr Soc 2010;​ 58:​1664-70. 11. O’Neil CK, Hanlon JT, Marcum ZA. Ad- verse effects of analgesics commonly used by older adults with osteoarthritis: focus on non-opioid and opioid analgesics. Am J Geriatr Pharmacother 2012;​10:​331-42. 12. Butler MM, Ancona RM, Beauchamp GA, et al. Emergency department pre- scription opioids as an initial exposure preceding addiction. Ann Emerg Med 2016;​68:​202-8. 13. Frank R. Targeting the opioid drug crisis:​a Health and Human Services ini- tiative. Health Affairs Blog. April 3, 2015 (http://healthaffairs​.org/​blog/​2015/​04/​03/​ targeting-the-opioid-drug-crisis-a-health -and-human-services-initiative/​). 14. Department of Health and Human Services Behavioral Health Coordinating Committee. Addressing prescription drug abuse in the United States: current activi- ties and future opportunities. 2014 (https:/​/​ www​.cdc​.gov/​drugoverdose/​pdf/​hhs _prescription_drug_abuse_report_09​ .2013​.pdf). 15. Kuo Y-F, Raji MA, Chen N-W, Hasan H, Goodwin JS. Trends in opioid prescrip- tions among Part D Medicare recipients from 2007 to 2012. Am J Med 2016;​129(2):​ 221.e21-221.e30. 16. Jena AB, Goldman D, Karaca-Mandic P. Hospital prescribing of opioids to Medicare beneficiaries. JAMA Intern Med 2016;​176:​990-7. 17. Poon SJ, Greenwood-Ericksen MB. The opioid prescription epidemic and the role of emergency medicine. Ann Emerg Med 2014;​64:​490-5. 18. Tamayo-Sarver JH, Dawson NV, Cy- dulka RK, Wigton RS, Baker DW. Vari- ability in emergency physician decision making about prescribing opioid analge- sics. Ann Emerg Med 2004;​43:​483-93. 19. Pletcher MJ, Kertesz SG, Kohn MA, Gonzales R. Trends in opioid prescribing The New England Journal of Medicine Downloaded from nejm.org on February 15, 2017. For personal use only. No other uses without permission. Copyright © 2017 Massachusetts Medical Society. All rights reserved.
  • 11. n engl j med 376;7 nejm.org  February 16, 2017 673 Opioid Prescribing and Risk of Long-Term Use by race/ethnicity for patients seeking care in US emergency departments. JAMA 2008;​299:​70-8. 20. Hoppe JA, Nelson LS, Perrone J, Wein- er SG. Opioid prescribing in a cross sec- tion of US emergency departments. Ann Emerg Med 2015;​66(3):​253-259.e1. 21. Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain — United States, 2016. JAMA 2016;​315:​1624-45. 22. Dunn KM, Saunders KW, Rutter CM, et al. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med 2010;​152:​85-92. 23. Braden JB, Russo J, Fan M-Y, et al. Emergency department visits among re- cipients of chronic opioid therapy. Arch Intern Med 2010;​170:​1425-32. 24. Jena AB, Goldman D, Weaver L, Kara- ca-Mandic P. Opioid prescribing by mul- tiple providers in Medicare: retrospective observational study of insurance claims. BMJ 2014;​348:​g1393. 25. Healthcare Cost and Utilization Proj- ect. Clinical Classifications Software (CCS) for ICD-9-CM (https:/​/​www​.hcup-us​.ahrq​ .gov/​toolssoftware/​ccs/​ccs​.jsp). 26. Meara E, Horwitz JR, Powell W, et al. State legal restrictions and prescription- opioid use among disabled adults. N Engl J Med 2016;​375:​44-53. 27. National Institute of Standards and Technology. Kolmogorov-Smirnov Good- ness-of-Fit Test. 2013 (http://www​.itl​.nist​ .gov/​div898/​handbook/​eda/​section3/​ eda35g​.htm). 28. White H. A heteroskedasticity-consis- tent covariance matrix and a direct test for heteroskedasticity. Econometrica 1980;​48:​ 817-38. 29. Angrist JD, Pischke J-S. Mostly harm- less econometrics: an empiricist’s com- panion. Princeton, NJ:​Princeton Univer- sity Press, 2008. Copyright © 2017 Massachusetts Medical Society. Tiger, Kanha National Park, India Anil Sain, M.D. The New England Journal of Medicine Downloaded from nejm.org on February 15, 2017. For personal use only. No other uses without permission. Copyright © 2017 Massachusetts Medical Society. All rights reserved.